
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Cuproptosis in prostate cancer: Molecular mechanisms, prognostic biomarkers and therapeutic frontiers of cuproptosis-related genes (Review) - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D711AC89B713F31C11AC003717A5EA.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="intjoncol">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331299/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="International Journal of Oncology">
<meta name="citation_title" content="Cuproptosis in prostate cancer: Molecular mechanisms, prognostic biomarkers and therapeutic frontiers of cuproptosis-related genes (Review)">
<meta name="citation_author" content="Zhugang Long">
<meta name="citation_author_institution" content="Department of Urology/Andrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China">
<meta name="citation_author_institution" content="School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China">
<meta name="citation_author" content="Yue Chang">
<meta name="citation_author_institution" content="School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China">
<meta name="citation_author" content="Kun Zhu">
<meta name="citation_author_institution" content="School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China">
<meta name="citation_author" content="Zhengyang Chen">
<meta name="citation_author_institution" content="School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China">
<meta name="citation_author" content="Yaodong You">
<meta name="citation_author_institution" content="Department of Urology/Andrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China">
<meta name="citation_author_institution" content="School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China">
<meta name="citation_publication_date" content="2025 Aug 4">
<meta name="citation_volume" content="67">
<meta name="citation_issue" content="3">
<meta name="citation_firstpage" content="77">
<meta name="citation_doi" content="10.3892/ijo.2025.5783">
<meta name="citation_pmid" content="40776742">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331299/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331299/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331299/pdf/ijo-67-03-05783.pdf">
<meta name="description" content="Prostate cancer (PCa) is among the most prevalent malignancies in males globally and management remains complex. In recent years, cuproptosis, an emerging form of cell death, has offered novel insights for PCa treatment. Cuproptosis refers to a ...">
<meta name="og:title" content="Cuproptosis in prostate cancer: Molecular mechanisms, prognostic biomarkers and therapeutic frontiers of cuproptosis-related genes (Review)">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Prostate cancer (PCa) is among the most prevalent malignancies in males globally and management remains complex. In recent years, cuproptosis, an emerging form of cell death, has offered novel insights for PCa treatment. Cuproptosis refers to a ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331299/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12331299">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3892/ijo.2025.5783"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ijo-67-03-05783.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12331299%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12331299/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12331299/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331299/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-intjoncol.gif" alt="International Journal of Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to International Journal of Oncology" title="Link to International Journal of Oncology" shape="default" href="http://www.spandidos-publications.com/ijo" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Int J Oncol</button></div>. 2025 Aug 4;67(3):77. doi: <a href="https://doi.org/10.3892/ijo.2025.5783" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3892/ijo.2025.5783</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Int%20J%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Int%20J%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int%20J%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Int%20J%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Cuproptosis in prostate cancer: Molecular mechanisms, prognostic biomarkers and therapeutic frontiers of cuproptosis-related genes (Review)</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Long%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Zhugang Long</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Zhugang Long</span></h3>
<div class="p">
<sup>1</sup>Department of Urology/Andrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China</div>
<div class="p">
<sup>2</sup>School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Long%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhugang Long</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yue Chang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yue Chang</span></h3>
<div class="p">
<sup>2</sup>School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yue Chang</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Kun Zhu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Kun Zhu</span></h3>
<div class="p">
<sup>2</sup>School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kun Zhu</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Zhengyang Chen</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Zhengyang Chen</span></h3>
<div class="p">
<sup>2</sup>School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhengyang Chen</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22You%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Yaodong You</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Yaodong You</span></h3>
<div class="p">
<sup>1</sup>Department of Urology/Andrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China</div>
<div class="p">
<sup>2</sup>School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22You%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yaodong You</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-ijo-67-03-05783">
<sup>1</sup>Department of Urology/Andrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China</div>
<div id="af2-ijo-67-03-05783">
<sup>2</sup>School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan 610075, P.R. China</div>
<div class="author-notes p">
<div class="fn" id="c1-ijo-67-03-05783">
<sup>✉</sup><p class="display-inline">Correspondence to: Professor Yaodong You, Department of Urology/Andrology, Hospital of Chengdu University of Traditional Chinese Medicine, 39 Shi-er-qiao Road, Chengdu, Sichuan 610072, P.R. China, E-mail: <span>yyd110@163.com</span></p>
</div>
<div class="fn" id="fn1-ijo-67-03-05783">
<sup>*</sup><p class="display-inline">Contributed equally</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 23; Accepted 2025 Jul 18; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright: © 2025 Long et al.</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-NonCommercial-NoDerivs License</a>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12331299  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40776742/" class="usa-link">40776742</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Prostate cancer (PCa) is among the most prevalent malignancies in males globally and management remains complex. In recent years, cuproptosis, an emerging form of cell death, has offered novel insights for PCa treatment. Cuproptosis refers to a copper-mediated cellular death mechanism that is intricately associated with mitochondrial metabolism, with cuproptosis-related genes (CRGs) exerting a notable effect on both cuproptosis and PCa. CRGs and other cuproptosis-associated indicators have demonstrated efficacy as prognostic predictors of PCa and these predictors may exhibit potential as novel therapeutic targets in the treatment of PCa. The mechanisms underlying cuproptosis in PCa remain to be fully elucidated; thus, further research is required to validate the expression patterns of CRGs and their associated indicators and examine the potential association with the characteristics, treatment responses and prognoses of patients with PCa. The present study aimed to investigate novel therapeutic strategies that may enhance the prognosis and quality of life of patients with PCa.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Key words:</strong> prostate cancer, cuproptosis, copper metabolism, cuproptosis-related genes, cell death</p></section></section><section id="sec1"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Prostate cancer (PCa) is among the most prevalent malignancies in males globally and has emerged as a notable public health concern (<a href="#b1-ijo-67-03-05783" class="usa-link" aria-describedby="b1-ijo-67-03-05783">1</a>). The pathophysiology of PCa is intricate and early-stage symptoms often go undetected; however, as the condition progresses, it may markedly affect the prognosis of patients and treatment efficacy (<a href="#b2-ijo-67-03-05783" class="usa-link" aria-describedby="b2-ijo-67-03-05783">2</a>,<a href="#b3-ijo-67-03-05783" class="usa-link" aria-describedby="b3-ijo-67-03-05783">3</a>). Androgen pathway inhibitors and chemotherapeutic medicines act as first-line therapeutic options for PCa, while prostate-specific antigen testing, multi-parametric magnetic resonance imaging and positron emission tomography-computed tomography imaging function as first-line diagnostic techniques, considerably enhancing the survival rates and prognosis of patients. Despite advancements in medical technology and the growing complexity of diagnostic and therapeutic approaches for PCa, the treatment and prognosis remain poor due to delayed diagnosis, postoperative recurrence, complications, complexities in treatment and resistance (<a href="#b4-ijo-67-03-05783" class="usa-link" aria-describedby="b4-ijo-67-03-05783">4</a>-<a href="#b6-ijo-67-03-05783" class="usa-link" aria-describedby="b6-ijo-67-03-05783">6</a>). For example, the effectiveness of non-selective immune checkpoint inhibitor therapy in patients remains ambiguous and its application in the early stages of treatment-resistant clones may promote the emergence of highly cross-resistant clones, thereby diminishing the clinical efficacy of subsequent androgen pathway inhibitor therapy (<a href="#b7-ijo-67-03-05783" class="usa-link" aria-describedby="b7-ijo-67-03-05783">7</a>). Thus, further investigations are required, to determine the specific pathophysiology of PCa and identify novel treatment targets that may improve patient prognoses.</p>
<p>In ~1980, researchers demonstrated that copper may be associated with programmed cell death (<a href="#b8-ijo-67-03-05783" class="usa-link" aria-describedby="b8-ijo-67-03-05783">8</a>). In 2022, Tsvetkov <em>et al</em> (<a href="#b9-ijo-67-03-05783" class="usa-link" aria-describedby="b9-ijo-67-03-05783">9</a>) highlighted a novel mechanism of copper-induced cell death; namely, cuproptosis (<a href="#b9-ijo-67-03-05783" class="usa-link" aria-describedby="b9-ijo-67-03-05783">9</a>). The results of this previous study provided novel insights into the role of copper in tumor growth. Cuproptosis is an emerging form of cell death in PCa, with evidence suggesting that it suppresses tumor progression. Inducing cuproptosis or modulating cuproptosis-related genes (CRGs) may exhibit potential as novel anti-cancer therapies. Thus, further investigations are required to determine the specific processes associated with cuproptosis and the potential role it may play in PCa.</p></section><section id="sec2"><h2 class="pmc_sec_title">2. Copper metabolism and mechanisms underlying cuproptosis</h2>
<p>Copper is vital for numerous biological functions (<a href="#b10-ijo-67-03-05783" class="usa-link" aria-describedby="b10-ijo-67-03-05783">10</a>). In mammals, copper is derived from food and is absorbed by intestinal epithelial cells in the duodenum and small intestine (<a href="#b11-ijo-67-03-05783" class="usa-link" aria-describedby="b11-ijo-67-03-05783">11</a>), a process that is carried out by copper transporter 1 (CTR1). Notably, this protein is located at the tip of intestinal epithelial cells and is mediated by the metal-reducing enzyme prostate six transmembrane epithelial antigen (STEAP) with duodenal cytochrome <em>b</em> activity. This activity prompts the reduction of Cu<sup>2+</sup> to Cu<sup>+</sup> (<a href="#b12-ijo-67-03-05783" class="usa-link" aria-describedby="b12-ijo-67-03-05783">12</a>,<a href="#b13-ijo-67-03-05783" class="usa-link" aria-describedby="b13-ijo-67-03-05783">13</a>), which is transferred to the bloodstream via the copper ion transport ATPase alpha peptide (ATP7A) (<a href="#b14-ijo-67-03-05783" class="usa-link" aria-describedby="b14-ijo-67-03-05783">14</a>). Upon entering the bloodstream, copper associates with soluble copper carrier proteins, referred to as copper chaperones (such as SLC31A1), which are transported by CTR1 and absorbed via the portal circulation system to reach the liver (<a href="#b15-ijo-67-03-05783" class="usa-link" aria-describedby="b15-ijo-67-03-05783">15</a>-<a href="#b19-ijo-67-03-05783" class="usa-link" aria-describedby="b19-ijo-67-03-05783">19</a>). Within hepatocytes, copper is released into the bloodstream via the ATPase copper ion transport, ATPase beta peptide (ATP7B), which subsequently binds to copper cyanoproteins and albumin, facilitating transport to other tissues in the body (<a href="#b20-ijo-67-03-05783" class="usa-link" aria-describedby="b20-ijo-67-03-05783">20</a>). Upon reaching target tissues, copper catalyzes reactions in various physiological processes (<a href="#b21-ijo-67-03-05783" class="usa-link" aria-describedby="b21-ijo-67-03-05783">21</a>-<a href="#b24-ijo-67-03-05783" class="usa-link" aria-describedby="b24-ijo-67-03-05783">24</a>). When copper levels in the body surpass the expected threshold, hepatocytes transport copper through ATP7B to bile and this travels through the bile ducts into the intestines, before being expelled in feces (<a href="#b25-ijo-67-03-05783" class="usa-link" aria-describedby="b25-ijo-67-03-05783">25</a>).</p>
<p>However, excessive accumulation of intracellular copper ions may be harmful to cells (<a href="#b26-ijo-67-03-05783" class="usa-link" aria-describedby="b26-ijo-67-03-05783">26</a>). Results of a previous study (<a href="#b27-ijo-67-03-05783" class="usa-link" aria-describedby="b27-ijo-67-03-05783">27</a>) indicated that excessively high copper levels promote the generation of reactive oxygen species (ROS), resulting in oxidative stress and DNA damage that may lead to cell death. Alterations in the valence state of copper ions result in harm to bio-organic molecules, including proteins, nucleic acids and lipids. These alterations may disrupt the production of iron-sulfur (Fe-S) clusters; thus, impacting enzyme activity (<a href="#b28-ijo-67-03-05783" class="usa-link" aria-describedby="b28-ijo-67-03-05783">28</a>). Excess copper ions associate with the lipoylated constituents of the tricarboxylic acid cycle (TCA) within mitochondria. Ferredoxin 1 (FDX1), a member of the ferredoxin protein family, co-regulates the proteolipoylation of proteins, such as dihydrolipoic acid S-acetyltransferase (DLAT) and lipoic acid synthetase (LIAS). FDX1 reduces Cu<sup>2+</sup> to Cu<sup>+</sup>, which exhibits higher levels of toxicity. This ion subsequently binds to lipoylated proteins, causing DLAT aggregation, resulting in proteotoxic stress and cellular apoptosis. Moreover, Cu<sup>+</sup> may destabilize the architecture of Fe-S cluster proteins and impede the synthesis of Fe-S proteins, which are integral to mitochondrial stability. The depletion of Fe-S cluster proteins markedly compromises cellular metabolic functions and energy maintenance, leading to an escalation of oxidative free radicals and the production of ROS, thereby increasing cytotoxicity and culminating in cell death (<a href="#f1-ijo-67-03-05783" class="usa-link">Fig. 1</a>). In addition, FDX1 and LIAS may be affected by cuproptosis, resulting in reduced expression (<a href="#b9-ijo-67-03-05783" class="usa-link" aria-describedby="b9-ijo-67-03-05783">9</a>,<a href="#b29-ijo-67-03-05783" class="usa-link" aria-describedby="b29-ijo-67-03-05783">29</a>,<a href="#b30-ijo-67-03-05783" class="usa-link" aria-describedby="b30-ijo-67-03-05783">30</a>). Thus, the homeostatic management of copper is crucial to avert cytotoxicity and sustain overall health. Notably, the processes and attributes of cuproptosis may exhibit potential in the treatment of specific disorders.</p>
<figure class="fig xbox font-sm" id="f1-ijo-67-03-05783"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12331299_ijo-67-03-05783-g00.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc24/12331299/1be7bfa2972b/ijo-67-03-05783-g00.jpg" loading="lazy" height="481" width="677" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1-ijo-67-03-05783/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Processes of copper metabolism and cuproptosis. Cu<sup>2+</sup> are reduced to Cu<sup>+</sup> by STEAP/DCYTB in the gut epithelium and transported into cells via CTR1. Inside target cells, Cu<sup>+</sup> interferes with Fe-S clusters, generates ROS and leads to mitochondrial dysfunction. Excess Cu<sup>+</sup> induces protein aggregation via lipoylated proteins, mediated by FDX1 and LIAS, ultimately causing cuproptosis. STEAP, prostate six transmembrane epithelial antigen; DCYTB, duodenal cytochrome <em>b</em>; CTR1, copper transporter 1; TCA, tricarboxylic acid cycle; Fe-S, iron-sulfur; ROS, reactive oxygen species; FDX1, ferredoxin 1; DLAT, dihydrolipoamide S-acetyltransferase; LIAS, lipoic acid synthetase.</p></figcaption></figure></section><section id="sec3"><h2 class="pmc_sec_title">3. Role of copper in tumor metabolism</h2>
<p>The identification of cuproptosis has offered novel insights into the initiation and advancement of tumor pathologies. Copper participates in the biological mechanisms of tumor proliferation and migration during the initial stages, activating metastasis-associated enzymes and signaling pathways to facilitate the spread of cancer (<a href="#b26-ijo-67-03-05783" class="usa-link" aria-describedby="b26-ijo-67-03-05783">26</a>). Notably, it binds to and activates critical molecules within various tumor signaling pathways (<a href="#b31-ijo-67-03-05783" class="usa-link" aria-describedby="b31-ijo-67-03-05783">31</a>,<a href="#b32-ijo-67-03-05783" class="usa-link" aria-describedby="b32-ijo-67-03-05783">32</a>), thereby influencing cancers directly or indirectly, and is intricately associated with the regulation of anti-tumor immunity (<a href="#b33-ijo-67-03-05783" class="usa-link" aria-describedby="b33-ijo-67-03-05783">33</a>). Moreover, copper directly influences or indirectly modifies the activity of key components, such as the Notch system; thus, affecting tumor angiogenesis, metabolism and inflammatory response (<a href="#b34-ijo-67-03-05783" class="usa-link" aria-describedby="b34-ijo-67-03-05783">34</a>). Copper also plays a key role in cancer cell proliferation (<a href="#b35-ijo-67-03-05783" class="usa-link" aria-describedby="b35-ijo-67-03-05783">35</a>) and results of a previous study (<a href="#b36-ijo-67-03-05783" class="usa-link" aria-describedby="b36-ijo-67-03-05783">36</a>) revealed that metallothionein, which is associated with copper storage, was markedly diminished in tumor tissues. Collectively, these results suggest that the capacity of cancer cells for regulating copper levels may be compromised. Moreover, copper facilitates angiogenesis, which is intricately associated with the advancement of malignant tumors (<a href="#b37-ijo-67-03-05783" class="usa-link" aria-describedby="b37-ijo-67-03-05783">37</a>,<a href="#b38-ijo-67-03-05783" class="usa-link" aria-describedby="b38-ijo-67-03-05783">38</a>). Results of previous studies (<a href="#b39-ijo-67-03-05783" class="usa-link" aria-describedby="b39-ijo-67-03-05783">39</a>-<a href="#b41-ijo-67-03-05783" class="usa-link" aria-describedby="b41-ijo-67-03-05783">41</a>) demonstrate that copper may activate numerous angiogenic factors and stabilize nuclear hypoxia-inducible factor-1, thereby augmenting the expression of pro-angiogenic factors. In addition, copper facilitated angiogenesis in numerous <em>in vitro</em> and <em>in vivo</em> models, whereas copper chelators inhibited tumor angiogenesis (<a href="#b42-ijo-67-03-05783" class="usa-link" aria-describedby="b42-ijo-67-03-05783">42</a>). Results of a further previous study (<a href="#b43-ijo-67-03-05783" class="usa-link" aria-describedby="b43-ijo-67-03-05783">43</a>) revealed that increased copper concentrations in tumor cells facilitated tumor angiogenesis, resulting in tumor advancement and spread. Consequently, increased copper concentrations may facilitate tumor development and progression. Excess copper levels may lead to cytotoxicity and trigger cuproptosis, which suppress tumor progression. Notably, excess copper-induced cuproptosis may exert inhibitory effects in numerous types of cancer (<a href="#b44-ijo-67-03-05783" class="usa-link" aria-describedby="b44-ijo-67-03-05783">44</a>). Copper exerts a dual influence on tumors and their metabolism, facilitating tumor cell proliferation and differentiation, while simultaneously suppressing proliferation and triggering apoptosis. This phenomenon is intricately associated with its biochemical characteristics and the complex tumor microenvironment (<a href="#b45-ijo-67-03-05783" class="usa-link" aria-describedby="b45-ijo-67-03-05783">45</a>).</p></section><section id="sec4"><h2 class="pmc_sec_title">4. Current status of cuproptosis research in PCa</h2>
<section id="sec5"><h3 class="pmc_sec_title">Cuproptosis and the progression of PCa</h3>
<p>Elevated copper concentrations in PCa cell tissues are a hallmark of patients with PCa (<a href="#b46-ijo-67-03-05783" class="usa-link" aria-describedby="b46-ijo-67-03-05783">46</a>), as demonstrated using <em>in vitro</em> cell line studies (<a href="#b47-ijo-67-03-05783" class="usa-link" aria-describedby="b47-ijo-67-03-05783">47</a>-<a href="#b49-ijo-67-03-05783" class="usa-link" aria-describedby="b49-ijo-67-03-05783">49</a>) and a xenograft mouse model (<a href="#b49-ijo-67-03-05783" class="usa-link" aria-describedby="b49-ijo-67-03-05783">49</a>,<a href="#b50-ijo-67-03-05783" class="usa-link" aria-describedby="b50-ijo-67-03-05783">50</a>). Notably, patients with PCa exhibit higher than expected serum copper levels (<a href="#b51-ijo-67-03-05783" class="usa-link" aria-describedby="b51-ijo-67-03-05783">51</a>-<a href="#b53-ijo-67-03-05783" class="usa-link" aria-describedby="b53-ijo-67-03-05783">53</a>) and elevated serum copper levels may be associated with a poor prognosis in patients with PCa (<a href="#b54-ijo-67-03-05783" class="usa-link" aria-describedby="b54-ijo-67-03-05783">54</a>). The RNA interference-mediated knockdown of CTR1 decreased copper ion absorption in PCa cells, resulting in the substantial inhibition of tumor growth (<a href="#b50-ijo-67-03-05783" class="usa-link" aria-describedby="b50-ijo-67-03-05783">50</a>). Collectively, these findings highlighted the role that increased copper ion concentrations may play in sustaining the biological processes of PCa cells, while diminished copper ion levels may fail to support the physiological functions of tumor cells.</p>
<p>Results of a previous study (<a href="#b31-ijo-67-03-05783" class="usa-link" aria-describedby="b31-ijo-67-03-05783">31</a>) reveal that the expression levels of CRGs in several types of tumor were markedly associated with patient prognosis, indicating that cuproptosis may play a key role in tumor biology and therapeutic response. Results of previous studies (<a href="#b51-ijo-67-03-05783" class="usa-link" aria-describedby="b51-ijo-67-03-05783">51</a>,<a href="#b55-ijo-67-03-05783" class="usa-link" aria-describedby="b55-ijo-67-03-05783">55</a>-<a href="#b60-ijo-67-03-05783" class="usa-link" aria-describedby="b60-ijo-67-03-05783">60</a>) indicate that individuals with malignant tumors, including PCa, exhibit markedly altered levels of Cu in both serum and tumor tissues. Moreover, CRGs play a role in PCa through predicting prognosis, modulating the tumor microenvironment and affecting therapeutic response (<a href="#b54-ijo-67-03-05783" class="usa-link" aria-describedby="b54-ijo-67-03-05783">54</a>). A range of CRGs may affect the progression of PCa, with CRGs and corresponding functions associated with cuproptosis detailed in <a href="#tI-ijo-67-03-05783" class="usa-link">Table I</a>. At present, research is focused on the potential of cuproptosis in preventing tumor growth. Consequently, the manipulation of cuproptosis or CRGs has emerged as a viable anti-cancer therapy.</p>
<section class="tw xbox font-sm" id="tI-ijo-67-03-05783"><h4 class="obj_head">Table I.</h4>
<div class="caption p"><p>Targets and roles of PCa-related CRGs in the cuproptosis process.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">First author/s, year</td>
<td valign="top" align="center" rowspan="1" colspan="1">Designation (of an object)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Target of action</td>
<td valign="top" align="center" rowspan="1" colspan="1">Role in cuproptosis</td>
<td valign="top" align="center" rowspan="1" colspan="1">(Refs.)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yang, 2022; Yang, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">FDX1</td>
<td valign="top" align="left" rowspan="1" colspan="1">Sites of lipoylation modification, Cu<sup>2+</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">Engaged in the lipoylation modification of proteins (DLAT, among others); Reduction of Cu<sup>2+</sup> to the more hazardous Cu<sup>+</sup> resulting in cuproptosis</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b61-ijo-67-03-05783" class="usa-link" aria-describedby="b61-ijo-67-03-05783">61</a>,<a href="#b62-ijo-67-03-05783" class="usa-link" aria-describedby="b62-ijo-67-03-05783">62</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">DLAT</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lipoylated protein, Cu<sup>2+</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cuproptosis triggered by lipoylation oligomerization</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b63-ijo-67-03-05783" class="usa-link" aria-describedby="b63-ijo-67-03-05783">63</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yang, 2022</td>
<td valign="top" align="left" rowspan="1" colspan="1">LIAS</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lipoylated protein</td>
<td valign="top" align="left" rowspan="1" colspan="1">Regulated by FDX1, involved in lipid acylation pathway</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b61-ijo-67-03-05783" class="usa-link" aria-describedby="b61-ijo-67-03-05783">61</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Li, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">DLD</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Engaged in TCA, wherein lipid acylation interacts with copper ions to trigger cuproptosis</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b64-ijo-67-03-05783" class="usa-link" aria-describedby="b64-ijo-67-03-05783">64</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Xiao, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">GCSH</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b65-ijo-67-03-05783" class="usa-link" aria-describedby="b65-ijo-67-03-05783">65</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Li, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">PDHA1</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b64-ijo-67-03-05783" class="usa-link" aria-describedby="b64-ijo-67-03-05783">64</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Li, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">DBT</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Key enzyme in TCA, binds to copper ions to induce cuproptosis</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b64-ijo-67-03-05783" class="usa-link" aria-describedby="b64-ijo-67-03-05783">64</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zhang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">CDKN2A</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cellular cycle and p53 signaling pathway</td>
<td valign="top" align="left" rowspan="1" colspan="1">Regulates the cell cycle and copper metabolism while inhibiting cuproptosis</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b66-ijo-67-03-05783" class="usa-link" aria-describedby="b66-ijo-67-03-05783">66</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Li, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">GLS</td>
<td valign="top" align="left" rowspan="1" colspan="1">Metabolic route of glutamine</td>
<td valign="top" align="left" rowspan="1" colspan="1">Oxidative stress in the TCA cycle mitigates tumors and prevents the occurrence of cuproptosis</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b64-ijo-67-03-05783" class="usa-link" aria-describedby="b64-ijo-67-03-05783">64</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Lin, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">NUDT21</td>
<td valign="top" align="left" rowspan="1" colspan="1">Genes associated with DHA biosynthesis and copper ion transport-related proteins</td>
<td valign="top" align="left" rowspan="1" colspan="1">Demethylation of these genes/proteins induces shortening of the 3′UTR, thereby suppressing DHA biosynthesis and conferring insensitivity to cuproptosis</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b67-ijo-67-03-05783" class="usa-link" aria-describedby="b67-ijo-67-03-05783">67</a>)</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/tI-ijo-67-03-05783/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tfn1-ijo-67-03-05783"><p>PCa, prostate cancer; CRGs, cuproptosis-related genes; TCA, tricarboxylic acid cycle; FDX1, ferredoxin 1; DLAT, dihydrolipoamide S-acetyltransferase; LIAS, lipoic acid synthase; DLD, dihydrolipoamide dehydrogenase; GCSH, glycine cleavage system protein H; PDHA1, pyruvate dehydrogenase E1 subunit alpha 1; DBT, dihydrolipoamide branched-chain transacylase E2; CDKN2A, cyclin-dependent kinase inhibitor 2A; GLS, glutaminase; NUDT21, nudix hydrolase 21; DHA, docosahexaenoic acid; 3′UTR, 3′ untranslated region.</p></div></div></section></section><section id="sec6"><h3 class="pmc_sec_title">Mechanisms underlying cuproptosis in PCa</h3>
<p>Mitochondrial dysfunction is pivotal for cuproptosis, resulting in oxidative damage to the mitochondrial membrane and compromised enzyme performance in the TCA cycle (<a href="#b29-ijo-67-03-05783" class="usa-link" aria-describedby="b29-ijo-67-03-05783">29</a>). By contrast, excessive copper accumulation in cellular mitochondria initiates cuproptosis (<a href="#b68-ijo-67-03-05783" class="usa-link" aria-describedby="b68-ijo-67-03-05783">68</a>), producing substantial amounts of ROS. During PCa progression, ROS levels are increased in PCa cells (<a href="#b69-ijo-67-03-05783" class="usa-link" aria-describedby="b69-ijo-67-03-05783">69</a>), resulting in DNA mutations, oncogene activation and tumor suppressor gene inactivation. This cascade facilitates malignant cell transformation and the activation of stress-responsive survival pathways, thereby exacerbating the aberrant proliferation of PCa cells (<a href="#b70-ijo-67-03-05783" class="usa-link" aria-describedby="b70-ijo-67-03-05783">70</a>). In addition, the process of cuproptosis generates ROS, further advancing PCa progression (<a href="#b71-ijo-67-03-05783" class="usa-link" aria-describedby="b71-ijo-67-03-05783">71</a>). Notably, a requisite level of ROS is essential for tumor cell growth and DNA mutation; however, severe oxidative stress may deplete the capabilities of the antioxidant system, resulting in apoptosis (<a href="#b72-ijo-67-03-05783" class="usa-link" aria-describedby="b72-ijo-67-03-05783">72</a>). In cuproptosis, ROS are continuously generated, leading to toxic concentrations in PCa cells and notable effects on tumor growth. Results of previous studies (<a href="#b73-ijo-67-03-05783" class="usa-link" aria-describedby="b73-ijo-67-03-05783">73</a>-<a href="#b75-ijo-67-03-05783" class="usa-link" aria-describedby="b75-ijo-67-03-05783">75</a>) indicate that the excessive creation and accumulation of ROS are employed to impede PCa progression. Moreover, soy isoflavones, such as genistein and soy glycosides, may elevate copper concentrations in PCa cells through mobilizing endogenous copper and disrupting the expression of copper transporter protein genes, CTR1 and ATP7A, in cancer cells. This process subsequently induced high levels of ROS production, ultimately resulting in apoptosis in PCa cells (<a href="#b76-ijo-67-03-05783" class="usa-link" aria-describedby="b76-ijo-67-03-05783">76</a>). Moreover, curcumin analogs (<a href="#b77-ijo-67-03-05783" class="usa-link" aria-describedby="b77-ijo-67-03-05783">77</a>) and felicidin (<a href="#b78-ijo-67-03-05783" class="usa-link" aria-describedby="b78-ijo-67-03-05783">78</a>) exhibit analogous mechanisms of action to impede PCa cell proliferation. Results of a previous study (<a href="#b79-ijo-67-03-05783" class="usa-link" aria-describedby="b79-ijo-67-03-05783">79</a>) reveal that alterations in the ATP7B gene inhibits the regulation of copper ion distribution <em>in vivo</em>, resulting in increased copper levels in PCa cells. Similarly, ATP7B protein levels were markedly enhanced in docetaxel-resistant PCa cell lines, resulting in diminished intracellular copper levels. Notably, these levels may be promoted through silencing ATP7B expression or using a combination of disulfiram and copper to enhance intracellular copper concentrations (<a href="#b80-ijo-67-03-05783" class="usa-link" aria-describedby="b80-ijo-67-03-05783">80</a>). This modified intra- and extracellular copper distribution results in a substantial inhibitory effect on PCa growth, which may be associated with the excessive production of ROS due to copper ion carriers entering PCa cells, as well as antioxidant deficiencies present in these cells (<a href="#b79-ijo-67-03-05783" class="usa-link" aria-describedby="b79-ijo-67-03-05783">79</a>). Results of a previous study (<a href="#b81-ijo-67-03-05783" class="usa-link" aria-describedby="b81-ijo-67-03-05783">81</a>) highlight a reciprocal interaction between cuproptosis and copper-induced oxidative stress. The accumulation of ROS may facilitate the progression of PCa and exert an inhibitory effect on it. Cuproptosis may induce excessive ROS production to promote tumor cell death; however, investigations surrounding this dual mechanism are limited (<a href="#f2-ijo-67-03-05783" class="usa-link">Fig. 2</a>). The specific impact of cuproptosis on PCa requires further validation through relevant experiments to elucidate the mechanism underlying cuproptosis in the context of PCa development.</p>
<figure class="fig xbox font-sm" id="f2-ijo-67-03-05783"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12331299_ijo-67-03-05783-g01.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc24/12331299/9914a4cf4e00/ijo-67-03-05783-g01.jpg" loading="lazy" height="481" width="677" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2-ijo-67-03-05783/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Dual mechanisms underlying copper and cuproptosis in PCa. Mitochondrial dysfunction is central to cuproptosis, leading to oxidative damage and inhibition of the TCA cycle. Excess copper accumulation in mitochondria triggers cuproptosis and sustained ROS production. Moderate ROS levels promote DNA mutations and oncogenic signaling, driving tumor progression. In contrast, excessive ROS overwhelm antioxidant defenses and induce tumor cell death. The specific involvement in PCa requires further validation. PCa, prostate cancer; TCA, tricarboxylic acid cycle; ROS, reactive oxygen species.</p></figcaption></figure><p>Copper participates in tumor metabolism and promotes tumor progression. Notably, copper is associated with the progression and spread of PCa (<a href="#b82-ijo-67-03-05783" class="usa-link" aria-describedby="b82-ijo-67-03-05783">82</a>,<a href="#b83-ijo-67-03-05783" class="usa-link" aria-describedby="b83-ijo-67-03-05783">83</a>) and it also facilitates tumor angiogenesis (<a href="#b37-ijo-67-03-05783" class="usa-link" aria-describedby="b37-ijo-67-03-05783">37</a>,<a href="#b38-ijo-67-03-05783" class="usa-link" aria-describedby="b38-ijo-67-03-05783">38</a>). Angiogenesis markedly contributes to the progression and metastasis of PCa (<a href="#b84-ijo-67-03-05783" class="usa-link" aria-describedby="b84-ijo-67-03-05783">84</a>), primarily driven by angiogenic factors, including vascular endothelial growth factor, fibroblast growth factor, hypoxia-inducible factor (HIF) and interleukin (<a href="#b85-ijo-67-03-05783" class="usa-link" aria-describedby="b85-ijo-67-03-05783">85</a>). Results of a previous study (<a href="#b79-ijo-67-03-05783" class="usa-link" aria-describedby="b79-ijo-67-03-05783">79</a>) reveal that a reduction in copper levels diminishes HIF activity and obstructed tumor angiogenesis. Moreover, restrictions in angiogenesis may limit PCa progression (<a href="#b86-ijo-67-03-05783" class="usa-link" aria-describedby="b86-ijo-67-03-05783">86</a>). Copper chelators may also diminish intracellular copper ion concentrations and lower copper bioavailability, thereby reducing copper-induced angiogenesis (<a href="#b42-ijo-67-03-05783" class="usa-link" aria-describedby="b42-ijo-67-03-05783">42</a>). Therefore, lowering copper concentrations to impede tumor angiogenesis may mitigate tumor advancement.</p>
<p>Complexities in lipid metabolism may contribute to carcinogenesis and disease progression. Results of a previous study (<a href="#b87-ijo-67-03-05783" class="usa-link" aria-describedby="b87-ijo-67-03-05783">87</a>) reveal that disturbances in lipid metabolism are associated with disease advancement and the development of castration-resistant prostate cancer (CRPC). In addition, cholesteryl esters (CE) are excessively accumulated in high-grade PCa and metastatic sites (<a href="#b88-ijo-67-03-05783" class="usa-link" aria-describedby="b88-ijo-67-03-05783">88</a>). The Wnt/β-catenin signaling pathway plays an important role in the metastasis of PCa and the depletion of CE markedly obstructs Wnt3a secretion through reducing unsaturated fatty acid levels, which inhibit the activation of the Wnt/β-catenin signaling pathway and restrict the acylation of Wnt3a, thereby inhibiting the metastasis of PCa (<a href="#b89-ijo-67-03-05783" class="usa-link" aria-describedby="b89-ijo-67-03-05783">89</a>). Copper ions also activate the Wnt/β-catenin signaling pathway, resulting in augmented cancer stem cell characteristics and increased resistance to numerous therapies (<a href="#b90-ijo-67-03-05783" class="usa-link" aria-describedby="b90-ijo-67-03-05783">90</a>). Elevated serum copper levels may be associated with increased serum total cholesterol and HDL cholesterol levels, as well as a heightened risk of dyslipidemia characterized by high serum total cholesterol and LDL cholesterol (<a href="#b91-ijo-67-03-05783" class="usa-link" aria-describedby="b91-ijo-67-03-05783">91</a>). Results of previous studies (<a href="#b92-ijo-67-03-05783" class="usa-link" aria-describedby="b92-ijo-67-03-05783">92</a>,<a href="#b93-ijo-67-03-05783" class="usa-link" aria-describedby="b93-ijo-67-03-05783">93</a>) reveal that zebrafish and grass carp exhibit elevated copper concentrations in their livers when subjected to excess copper, resulting in increased lipid accumulation and levels of triglycerides. These findings indicate that alterations in copper levels, particularly in excess, may influence the progression of PCa by affecting lipid metabolism and signaling system activity; however, further molecular or animal studies are required to validate these mechanisms.</p>
<p>In conclusion, the mechanisms underlying cuproptosis in PCa primarily encompass oxidative stress, intracellular copper distribution, angiogenesis and lipid metabolism dysregulation. Further investigations into these mechanisms may facilitate a deeper comprehension of cuproptosis in PCa and aid in identifying potential therapeutic targets.</p></section><section id="sec7"><h3 class="pmc_sec_title">Integrated therapeutic approaches for PCa predicated on cuproptosis, including carriers of copper ions</h3>
<p>Elesclomol (ES) is a copper ion transporter that facilitates the entry of copper ions into cells, often targeting mitochondria. The entry of copper into cells leads to the accumulation of ROS, consequently impeding tumor growth. In cancer therapy, ES may leverage its capacity to produce cuproptosis to eliminate malignant cells. Disulfiram (DSF) functions as a copper ion transporter through binding to copper ions and facilitating entry into the cell. Notably, DSF has previously been investigated for the treatment of specific types of cancer, particularly those with elevated levels of lipoylated proteins (<a href="#b94-ijo-67-03-05783" class="usa-link" aria-describedby="b94-ijo-67-03-05783">94</a>). The two aforementioned copper ion carriers have been extensively researched for their ability to carry Cu<sup>2+</sup> into cells or mitochondria to facilitate copper-dependent cell death (<a href="#f3-ijo-67-03-05783" class="usa-link">Fig. 3</a>). Copper exerts a multifaceted impact on PCa growth and proliferation; however, results of <em>in vitro</em> studies (<a href="#b61-ijo-67-03-05783" class="usa-link" aria-describedby="b61-ijo-67-03-05783">61</a>,<a href="#b62-ijo-67-03-05783" class="usa-link" aria-describedby="b62-ijo-67-03-05783">62</a>) consistently demonstrate that ES diminishes PCa cell viability via a reduction in FDX1 expression levels. Moreover, ES promotes keratin formation in tumor cells, inhibits autophagy in PCa via the DLAT/mammalian target of rapamycin pathway and enhances sensitivity to docetaxel and paclitaxel chemotherapy (<a href="#b95-ijo-67-03-05783" class="usa-link" aria-describedby="b95-ijo-67-03-05783">95</a>). In addition, DSF compounds combined with copper have demonstrated efficacy in breast cancer treatment through downregulating the expression of the phosphatase and tensin homolog (PTEN) associated with human chromosome 10 deletion and activating protein kinase B (AKT) signaling. This indicates a potential for combination therapy utilizing phosphatidylinositol 3-kinase (PI3K)/AKT inhibitors (<a href="#b96-ijo-67-03-05783" class="usa-link" aria-describedby="b96-ijo-67-03-05783">96</a>). Results of further previous studies (<a href="#b97-ijo-67-03-05783" class="usa-link" aria-describedby="b97-ijo-67-03-05783">97</a>,<a href="#b98-ijo-67-03-05783" class="usa-link" aria-describedby="b98-ijo-67-03-05783">98</a>) reveal that PCa may involve the same PTEN and PI3K/AKT signaling pathways for targeted therapy, highlighting that these pathways may inhibit PCa progression. However, previous investigations focused on the role of PTEN and PI3K/AKT signaling pathways in PCa progression remain limited.</p>
<figure class="fig xbox font-sm" id="f3-ijo-67-03-05783"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12331299_ijo-67-03-05783-g02.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc24/12331299/c76bf8d225e7/ijo-67-03-05783-g02.jpg" loading="lazy" height="481" width="677" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f3-ijo-67-03-05783/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mechanism of copper ion carriers. Elesclomol and disulfiram enhance intracellular Cu<sup>+</sup> accumulation in tumor cells. In the presence of elevated lipoylated proteins or ALDH expression (such as PCa), Cu<sup>+</sup> induces toxic stress within mitochondria, triggering cuproptosis and resulting in tumor cell death. ALDH, acetaldehyde dehydrogenase; PCa, prostate cancer.</p></figcaption></figure><p>Moreover, ES may exhibit potential in the treatment of PCa. Results of a previous study (<a href="#b99-ijo-67-03-05783" class="usa-link" aria-describedby="b99-ijo-67-03-05783">99</a>) revealed that DSF may inhibit the proliferation of PCa cell lines and this mechanism may be mediated by other pharmacological agents or specific sensitizers, such as copper (<a href="#b100-ijo-67-03-05783" class="usa-link" aria-describedby="b100-ijo-67-03-05783">100</a>). Thus, copper may be used to suppress the growth of PCa cells (<a href="#b49-ijo-67-03-05783" class="usa-link" aria-describedby="b49-ijo-67-03-05783">49</a>,<a href="#b101-ijo-67-03-05783" class="usa-link" aria-describedby="b101-ijo-67-03-05783">101</a>), ultimately improving the survival rate of patients (<a href="#b80-ijo-67-03-05783" class="usa-link" aria-describedby="b80-ijo-67-03-05783">80</a>).</p>
<p>Collectively, these results revealed that although copper ion carrier-induced cell death is a key form of cell death, few studies have confirmed the efficacy in PCa using <em>in vitro</em> investigations. Results of previous research demonstrated that several substances may elevate intracellular copper ion concentrations, including the aforementioned copper ion carriers, copper ion compounds and several copper chelators that inhibit the increase in copper ion levels. Triethylenetetramine dihydrochloride (<a href="#b102-ijo-67-03-05783" class="usa-link" aria-describedby="b102-ijo-67-03-05783">102</a>), 8-hydroxyquinoline (<a href="#b103-ijo-67-03-05783" class="usa-link" aria-describedby="b103-ijo-67-03-05783">103</a>), penicillamine (<a href="#b104-ijo-67-03-05783" class="usa-link" aria-describedby="b104-ijo-67-03-05783">104</a>), methanobactin (<a href="#b105-ijo-67-03-05783" class="usa-link" aria-describedby="b105-ijo-67-03-05783">105</a>), Bathocuproine disulphonate (<a href="#b106-ijo-67-03-05783" class="usa-link" aria-describedby="b106-ijo-67-03-05783">106</a>) and choline tetrathiomolybdate (<a href="#b107-ijo-67-03-05783" class="usa-link" aria-describedby="b107-ijo-67-03-05783">107</a>) are key compounds that regulate intracellular copper ion concentrations, thereby facilitating or obstructing copper ion-associated biological functions. The aforementioned drugs are theoretically capable of stimulating cell proliferation; however, no previous investigations have been undertaken regarding cuproptosis in PCa. Preliminary experiments should be performed to substantiate this hypothesis and to aid in the development of novel cuproptosis-associated therapies.</p></section><section id="sec8"><h3 class="pmc_sec_title">Chelators of copper ions</h3>
<p>A reduction in glutathione (GSH), a natural chelator of intracellular copper ions, results in an elevation of intracellular copper concentration, ultimately culminating in cell death (<a href="#b9-ijo-67-03-05783" class="usa-link" aria-describedby="b9-ijo-67-03-05783">9</a>). In healthy prostate cells, GSH neutralizes ROS produced by increased copper ion levels from copper ion carriers; thus, providing an antioxidant effect and reducing sensitivity to ROS. Conversely, PCa cells possess diminished levels of GSH and are deficient in antioxidants, rendering them susceptible to ROS generated by copper ion carriers. Subsequently, this may result in PCa cell mortality (<a href="#b79-ijo-67-03-05783" class="usa-link" aria-describedby="b79-ijo-67-03-05783">79</a>). In addition, elevated copper concentrations facilitate tumor angiogenesis and disrupt lipid metabolism. Steroid-based compounds impede PCa progression through the inhibition of CTR, thereby decreasing copper absorption by PCa cells and mitigating the proliferative effects of copper. These results indicate that the aforementioned compounds may represent innovative anticancer agents targeting anti-copper therapy (<a href="#b35-ijo-67-03-05783" class="usa-link" aria-describedby="b35-ijo-67-03-05783">35</a>). Results of a further study (<a href="#b108-ijo-67-03-05783" class="usa-link" aria-describedby="b108-ijo-67-03-05783">108</a>) reveal that the pro-drug, gamma-glutamyl transferase-activated prochelator releasing dithiocarbamate (GGTDTC), is activated by gamma-glutamyl transferase (GGT) in PCa cells. The release of dithiocarbamate (DTC), which chelates with copper ions to form a Cu-DTC complex, is highly toxic and promotes PCa cell death by triggering oxidative stress to generate large amounts of ROS. Ultimately, this interferes with protein ubiquitination. In PCa cells, GGT is often overexpressed and the concentration of copper ions is high. In addition, GGT exhibits a decreased antioxidant capacity, leading to metabolic disorders. This compound is more selective to cancer cells and therefore less toxic to non-tumor cells. In addition, GGT exhibits improved selectivity (<a href="#b108-ijo-67-03-05783" class="usa-link" aria-describedby="b108-ijo-67-03-05783">108</a>). Thus, the use of copper chelators, in addition to elevated copper ion concentrations that mediate cuproptosis and impede tumor advancement, may diminish intracellular copper levels and initiate cuproptosis. These compounds may be used to leverage the highly toxic characteristics of copper-chelator complexes, which may further inhibit tumor progression to some degree. However, the specific mechanisms remain to be fully elucidated.</p></section><section id="sec9"><h3 class="pmc_sec_title">Copper nanoparticles</h3>
<p>Nanotechnology facilitates the targeted delivery of copper ions to tumor sites via modifying responsive groups that coordinate with copper compounds. This process enhances the concentration of copper ions within tumor cells, leading to the toxic oligomerization of lipoylated proteins and the degradation of Fe-S cluster proteins. This ultimately induces cuproptosis in tumor cells and produces a therapeutic effect against cancer (<a href="#b109-ijo-67-03-05783" class="usa-link" aria-describedby="b109-ijo-67-03-05783">109</a>). Researchers presented a novel nanoparticle, DCM@GDY-CuMOF@DOX, capable of releasing Cu<sup>+</sup> in the presence of GSH, ultimately facilitating the onset of cuproptosis (<a href="#b110-ijo-67-03-05783" class="usa-link" aria-describedby="b110-ijo-67-03-05783">110</a>). Concurrently, doxorubicin (DOX) generates high levels of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), which, when catalyzed by Cu<sup>+</sup>, is transformed into cytotoxic ROS via a Fenton-like reaction. Notably, this process induces cancer cell death. ROS produced via this method may trigger apoptosis, resulting in oxidative DNA damage and mitochondrial impairment. By contrast to the administration of DOX alone, nanoparticles enveloped within the PCa cell membranes (DU145 cell membrane; DCM) exhibit isotypic targeting capabilities, allowing them to specifically identify and target identical PCa cells. This process may diminish the likelihood of non-specific targeting during blood circulation. The non-specific adsorption and elimination in the bloodstream extend circulation time within the body, thereby minimizing toxicity to healthy tissues and enhancing the precision of targeting PCa cells for treatment. Haemolysis experiments, histopathological assessments and serum biochemical analyses demonstrated that nanoparticles did not induce notable damage to healthy cells and tissues; however, they did exhibit targeting capabilities and biocompatibility. Thus, these may exhibit potential in clinical practice (<a href="#b110-ijo-67-03-05783" class="usa-link" aria-describedby="b110-ijo-67-03-05783">110</a>). Results of a previous study (<a href="#b111-ijo-67-03-05783" class="usa-link" aria-describedby="b111-ijo-67-03-05783">111</a>) demonstrate that cuprous oxide nanoparticles (CONPs) selectively inhibited the proliferation of CRPC cells. Toxicological investigations revealed that CONPs elevate copper demand and uptake capacity and induce cell cycle arrest and apoptosis in cancer cells. In addition, CONPs suppressed stem cell properties and the Wnt signaling pathway and exhibited minimal effects on healthy prostate epithelial cells. Moreover, Cu(DDC)<sub>2</sub> nanoparticles facilitate the transport of Cu<sup>2+</sup> into cells, elevate intracellular copper levels and mediate the apoptosis of paclitaxel-resistant PCa cells (<a href="#b112-ijo-67-03-05783" class="usa-link" aria-describedby="b112-ijo-67-03-05783">112</a>). These nanoparticles facilitated tumor site-specific accumulation and induce cuproptosis through loading copper ions and employing a responsive release mechanism, offering a novel, targeted and biocompatible therapeutic alternative for PCa treatment.</p>
<p>Moreover, liposomal copper (LpCu) effectively transports copper ions into PCa cells via encapsulating copper salts within liposomes. PCa cells treated with LpCu exhibit metabolic toxicity comparable with that of free copper salts, indicated by increased intracellular copper levels and increased levels of ROS, apoptosis and necrosis (<a href="#b113-ijo-67-03-05783" class="usa-link" aria-describedby="b113-ijo-67-03-05783">113</a>). Specific steroid-based compounds form complexes with copper ions, diminishing the concentration of free copper ions within the cell. Thus, the influx of copper ions into PCa cells via CTR1 is reduced, effectively impeding copper absorption by PCa cells and disrupting their biosynthesis to inhibit PCa cell proliferation (<a href="#b35-ijo-67-03-05783" class="usa-link" aria-describedby="b35-ijo-67-03-05783">35</a>).</p></section><section id="sec10"><h3 class="pmc_sec_title">Adjuvant therapy and targeted prediction of cuproptosis in PCa</h3>
<p>Surgery remains the primary treatment option for localized PCa and androgen deprivation therapy is effective for patients with biochemically recurrent and metastatic hormone-sensitive PCa. However, resistance and progression to CRPC may still occur, along with suboptimal therapeutic outcomes following chemotherapy and immunotherapy (<a href="#b54-ijo-67-03-05783" class="usa-link" aria-describedby="b54-ijo-67-03-05783">54</a>). At present, research is focused on the role of cuproptosis in malignancies, to determine the effects on cell growth and the specific underlying mechanisms.</p>
<p>Cuproptosis affects treatment resistance and contributes to the management of PCa. Notably, enzalutamide augments the susceptibility of CRPC cells to copper ion carriers and improves treatment efficacy through facilitating copper-dependent cell death. This combination therapy efficiently suppresses the proliferation of CRPC cells and reverses the resistance of enzalutamide-resistant cells both <em>in vitro</em> and <em>in vivo</em> (<a href="#b43-ijo-67-03-05783" class="usa-link" aria-describedby="b43-ijo-67-03-05783">43</a>). By contrast, enzalutamide-resistant PCa cells demonstrate high levels of resistance to cuproptosis and the alteration of NUDT21 activity or the addition of PDHA improve the effectiveness of the copper ionophore, potentially leading to treatment resistance in PCa (<a href="#b67-ijo-67-03-05783" class="usa-link" aria-describedby="b67-ijo-67-03-05783">67</a>). Results of a further previous study revealed that a combination of disulfiram and copper led to a notable reduction in the expression of ATP7B and the elevation of intracellular copper levels in PCa cell lines, rendering resistant cells sensitive to the growth-inhibitory and apoptotic effects of docetaxel (<a href="#b80-ijo-67-03-05783" class="usa-link" aria-describedby="b80-ijo-67-03-05783">80</a>). Results of both <em>in vivo</em> and <em>in vitro</em> studies demonstrate that a combination of DSF and copper markedly reduces cell proliferation and the induction of apoptosis, indicative of the increased antitumor efficacy of docetaxel (<a href="#b80-ijo-67-03-05783" class="usa-link" aria-describedby="b80-ijo-67-03-05783">80</a>). Moreover, DSF and copper directly interact with ATP7B, leading to the downregulation of its downstream proteins, including copper metabolism MURR1 Domain containing 1, α-clusterin and S-phase kinase associated protein 2. Simultaneously, DSF and copper promote upregulation of cyclin-dependent kinase inhibitor 1 thus inhibiting tumor growth (<a href="#b80-ijo-67-03-05783" class="usa-link" aria-describedby="b80-ijo-67-03-05783">80</a>). Results of a previous study (<a href="#b95-ijo-67-03-05783" class="usa-link" aria-describedby="b95-ijo-67-03-05783">95</a>) reveal that a combination of ES and CuCl<sub>2</sub> (ES-Cu) effectively induces copper-mediated cytotoxicity in PCa cells, inhibits autophagy via DLAT upregulation and subsequently promotes cell retention in the G<sub>2</sub>/M phase, thereby augmenting the chemotherapeutic efficacy of docetaxel. <em>In vivo</em> experiments further demonstrate that the combination of ES-Cu and docetaxel markedly suppresses tumor growth in a PCa transplantation model using nude mice, where tumor proliferation was markedly inhibited (<a href="#b95-ijo-67-03-05783" class="usa-link" aria-describedby="b95-ijo-67-03-05783">95</a>). Collectively, these data indicated that copper-induced cell death may impact the sensitivity of PCa to pharmacological agents.</p>
<p>Complanatoside A (CA) is a flavonoid derived from the Traditional Chinese Medicine, <em>Semen Astragali Complanati</em>. Results of a previous study (<a href="#b114-ijo-67-03-05783" class="usa-link" aria-describedby="b114-ijo-67-03-05783">114</a>) reveal that CA downregulates the expression of the copper efflux-associated protein, ATOX1, promotes the accumulation of intracellular copper ions, inhibits mitochondrial activity and induces copper-mediated cell death. Notably, this agent markedly suppresses the proliferation, invasion and growth of PCa cells both <em>in vivo</em> and <em>ex vivo</em>, with no notable damage to major organs in experimental animal models (<a href="#b114-ijo-67-03-05783" class="usa-link" aria-describedby="b114-ijo-67-03-05783">114</a>). Nuclear factor-activated T cell 5 (NFAT5) is a transcription factor that activates T cells and plays a key role in cellular stress response, immunological response and cell proliferation. Results of previous study revealed that NFAT5 acts as a target gene of microRNA (miR)-206 through bioinformatics analysis and database predictions. In addition, results of a previous study (<a href="#b115-ijo-67-03-05783" class="usa-link" aria-describedby="b115-ijo-67-03-05783">115</a>) reveal that the long-chain non-coding RNA (lncRNA), <a href="https://www.ncbi.nlm.nih.gov/nuccore/AP000842.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">AP000842.3</a>, acts as a target gene of miR-206, functioning as a competitive endogenous RNA (ceRNA) that modulates the expression levels of NFAT5. Thus, this lncRNA affects the sensitivity of PCa cells to copper death inducers. In cellular experiments, NFAT5 knockdown markedly increases the sensitivity of PCa cells to copper-induced cytotoxicity and this was highlighted by elevated intracellular copper ion concentrations and reduced ROS levels (<a href="#b115-ijo-67-03-05783" class="usa-link" aria-describedby="b115-ijo-67-03-05783">115</a>). Therefore, the interaction of lncRNA <a href="https://www.ncbi.nlm.nih.gov/nuccore/AP000842.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">AP000842.3</a> with miR-206 may play a key role in regulating NFAT5 expression. Notably, this regulatory mechanism may be partly dependent on miR-206, providing a novel potential target for PCa diagnosis and treatment (<a href="#b115-ijo-67-03-05783" class="usa-link" aria-describedby="b115-ijo-67-03-05783">115</a>).</p>
<p>Resveratrol, a polyphenol compound mainly located in red grapes and pomegranates, is an antioxidant that inhibits PCa cells through interacting with copper ions. This process contributes to the redox of copper ions and the generation of ROS, leading to an increase in intracellular oxidative stress and interference with intracellular signaling pathways, such as MAPK, PI3K/Akt and NF-κB pathways. Moreover, results of a this study (<a href="#b116-ijo-67-03-05783" class="usa-link" aria-describedby="b116-ijo-67-03-05783">116</a>) reveal that resveratrol inhibits cell cycle progression, thus inhibiting PCa cell proliferation. This compound also activates key intracellular apoptotic signaling pathways, such as the mitochondrial pathway and death receptor pathway, to promote the apoptosis of PCa cells. By contrast, copper ion chelation reverses the anticancer effects of resveratrol, further confirming the key role of copper ions in the action of resveratrol. In addition, the observed elevation of copper ions may facilitate their absorption and storage, promoting the harmful effects of resveratrol through the upregulation of the copper transporter protein, CTR (<a href="#b116-ijo-67-03-05783" class="usa-link" aria-describedby="b116-ijo-67-03-05783">116</a>). Collectively, results of these investigations indicated that copper and copper-induced cytotoxicity may serve as viable therapeutic approaches for the treatment of PCa.</p>
<p>Despite the limited number of studies on cuproptosis in PCa, previous studies revealed that CRGs may act as novel therapeutic targets, playing a key role in the progression of PCa (<a href="#tII-ijo-67-03-05783" class="usa-link">Table II</a>). Moreover, cuproptosis may be associated with key predictors of PCa, exhibiting potential as a novel indicator of the prognosis of patients with PCa and their responsiveness to treatment (<a href="#tIII-ijo-67-03-05783" class="usa-link">Table III</a>).</p>
<section class="tw xbox font-sm" id="tII-ijo-67-03-05783"><h4 class="obj_head">Table II.</h4>
<div class="caption p"><p>Correlation between CRGs and PCa.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">First author/s, year</th>
<th valign="top" align="center" rowspan="1" colspan="1">CRGs</th>
<th valign="top" align="center" rowspan="1" colspan="1">Sources for screening</th>
<th valign="top" align="center" rowspan="1" colspan="1">Association with PCa</th>
<th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yang, 2022; Yang, 2024; Wang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">FDX1</td>
<td valign="top" align="left" rowspan="1" colspan="1">Genome-wide screening utilizing CRISPR/Cas9 technology</td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated expression correlates with unfavorable prognosis; Inverse connection with immune cell infiltration, cellular autophagy and drug sensitivity</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b61-ijo-67-03-05783" class="usa-link" aria-describedby="b61-ijo-67-03-05783">61</a>,<a href="#b62-ijo-67-03-05783" class="usa-link" aria-describedby="b62-ijo-67-03-05783">62</a>,<a href="#b117-ijo-67-03-05783" class="usa-link" aria-describedby="b117-ijo-67-03-05783">117</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yang, 2023; Wang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">DLAT</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated expression correlates with favorable prognosis and positively connected with immune cell infiltration</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b63-ijo-67-03-05783" class="usa-link" aria-describedby="b63-ijo-67-03-05783">63</a>,<a href="#b117-ijo-67-03-05783" class="usa-link" aria-describedby="b117-ijo-67-03-05783">117</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yang, 2024; Wang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">LIAS</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated expression correlates with a favorable outcome</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b62-ijo-67-03-05783" class="usa-link" aria-describedby="b62-ijo-67-03-05783">62</a>,<a href="#b117-ijo-67-03-05783" class="usa-link" aria-describedby="b117-ijo-67-03-05783">117</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Li, 2024; Wang, 2023; Cheng, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">PDHA1</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated expression correlates with diminished bad prognosis, treatment resistance and DFS</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b64-ijo-67-03-05783" class="usa-link" aria-describedby="b64-ijo-67-03-05783">64</a>,<a href="#b117-ijo-67-03-05783" class="usa-link" aria-describedby="b117-ijo-67-03-05783">117</a>,<a href="#b118-ijo-67-03-05783" class="usa-link" aria-describedby="b118-ijo-67-03-05783">118</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Wang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">CDKN2A<br>DLD</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated expression correlated with unfavorable prognosis and decreased DFS</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b117-ijo-67-03-05783" class="usa-link" aria-describedby="b117-ijo-67-03-05783">117</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Li, 2024; Wang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">GLS</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated expression correlates with unfavorable prognosis</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b64-ijo-67-03-05783" class="usa-link" aria-describedby="b64-ijo-67-03-05783">64</a>,<a href="#b117-ijo-67-03-05783" class="usa-link" aria-describedby="b117-ijo-67-03-05783">117</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Xiao, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">GCSH</td>
<td valign="top" align="left" rowspan="1" colspan="1">Analysis of expression levels using the StarBase and GEPIA databases</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b65-ijo-67-03-05783" class="usa-link" aria-describedby="b65-ijo-67-03-05783">65</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yang, 2024; Li, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">DBT</td>
<td valign="top" align="left" rowspan="1" colspan="1">Analysis of differential expression in TCGA and GEO datasets</td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated expression correlates with a favorable outcome</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b62-ijo-67-03-05783" class="usa-link" aria-describedby="b62-ijo-67-03-05783">62</a>,<a href="#b64-ijo-67-03-05783" class="usa-link" aria-describedby="b64-ijo-67-03-05783">64</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tII-ijo-67-03-05783/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tfn2-ijo-67-03-05783"><p>CRGs, cuproptosis-related genes; PCa, prostate cancer; FDX1, ferredoxin 1; DLAT, dihydrolipoamide S-acetyltransferase; LIAS, lipoic acid synthase; PDHA1, pyruvate dehydrogenase E1 subunit alpha 1; CDKN2A, cyclin-dependent kinase inhibitor 2A; DLD, dihydrolipoamide dehydrogenase; GLS, glutaminase; GCSH, glycine cleavage system protein H; DBT, dihydrolipoamide branched-chain transacylase E2; CRISPR/Cas9, clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9; DFS, disease-free survival; GEPIA, Gene Expression Profiling Interactive Analysis; TCGA, The Cancer Genome Atlas; GEO, Gene Expression Omnibus.</p></div></div></section><section class="tw xbox font-sm" id="tIII-ijo-67-03-05783"><h4 class="obj_head">Table III.</h4>
<div class="caption p"><p>Summary of PCa prediction models based on cuproptosis.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">First author/s, year</th>
<th valign="top" align="center" rowspan="1" colspan="1">Forecasting model</th>
<th valign="top" align="center" rowspan="1" colspan="1">Construction methods</th>
<th valign="top" align="center" rowspan="1" colspan="1">Forecasting metrics</th>
<th valign="top" align="center" rowspan="1" colspan="1">Prominent application domains in PCa</th>
<th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yang, 2024; Li, 2024; Wang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">CRGs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Sequential LASSO Cox regression</td>
<td valign="top" align="left" rowspan="1" colspan="1">FDX1, DLAT, DLD, PDHA1, CDKN2A, DBT, GLS and others</td>
<td valign="top" align="left" rowspan="1" colspan="1">Assessment of relapse risk, treatment efficacy and DFS</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b62-ijo-67-03-05783" class="usa-link" aria-describedby="b62-ijo-67-03-05783">62</a>,<a href="#b64-ijo-67-03-05783" class="usa-link" aria-describedby="b64-ijo-67-03-05783">64</a>,<a href="#b117-ijo-67-03-05783" class="usa-link" aria-describedby="b117-ijo-67-03-05783">117</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Jin, 2022</td>
<td valign="top" align="left" rowspan="1" colspan="1">CRGs evaluations</td>
<td valign="top" align="left" rowspan="1" colspan="1">Univariate Cox regression</td>
<td valign="top" align="left" rowspan="1" colspan="1">DLAT, FDX1, DLD, LIAS, GLS, PDHA1, CDKN2A and others</td>
<td valign="top" align="left" rowspan="1" colspan="1">Recommendations for individualized immunotherapy approaches</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b119-ijo-67-03-05783" class="usa-link" aria-describedby="b119-ijo-67-03-05783">119</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Wang, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">Gleason scores and CRGs</td>
<td valign="top" align="left" rowspan="1" colspan="1">LASSO Cox and multifactorial Cox regression</td>
<td valign="top" align="left" rowspan="1" colspan="1">Five particular genes (STX3, CABLES2, E2F5, RALA and POLE3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Personalized therapy and administration</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b120-ijo-67-03-05783" class="usa-link" aria-describedby="b120-ijo-67-03-05783">120</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yao, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cuproptosis-related immunization risk score</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Three immune-related CRGs (PRLR, DES and LECT2)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Evaluation of OS and DFS</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b121-ijo-67-03-05783" class="usa-link" aria-describedby="b121-ijo-67-03-05783">121</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zhang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">CRGs and PCa expression correlate</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Five particular genes (B4GALNT4, FAM83D, COL1A, CHRM3 and MYBPC1)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Prediction of responsiveness to chemotherapy and immunotherapy</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b122-ijo-67-03-05783" class="usa-link" aria-describedby="b122-ijo-67-03-05783">122</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Ma, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">Necrosis and CRGs</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">CDI</td>
<td valign="top" align="left" rowspan="1" colspan="1">Assessment of survival and recurrence risk</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b123-ijo-67-03-05783" class="usa-link" aria-describedby="b123-ijo-67-03-05783">123</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Cheng, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">CRLs related with cuproptosis</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Six CRLs</td>
<td valign="top" align="left" rowspan="1" colspan="1">DFS prognosis, evaluation of the immune microenvironment</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b124-ijo-67-03-05783" class="usa-link" aria-describedby="b124-ijo-67-03-05783">124</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Ma, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Twelve CRLs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Evaluation of OS and DFS</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b125-ijo-67-03-05783" class="usa-link" aria-describedby="b125-ijo-67-03-05783">125</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Jiang, 2022</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Six CRLs</td>
<td valign="top" align="left" rowspan="1" colspan="1">DFS evaluation</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b126-ijo-67-03-05783" class="usa-link" aria-describedby="b126-ijo-67-03-05783">126</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zhong, 2025</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b127-ijo-67-03-05783" class="usa-link" aria-describedby="b127-ijo-67-03-05783">127</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Ren, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Assessment of relapse risk</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b128-ijo-67-03-05783" class="usa-link" aria-describedby="b128-ijo-67-03-05783">128</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Yu, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b129-ijo-67-03-05783" class="usa-link" aria-describedby="b129-ijo-67-03-05783">129</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Lu, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Three CRLs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Prognostic assessment for progression-free survival</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b130-ijo-67-03-05783" class="usa-link" aria-describedby="b130-ijo-67-03-05783">130</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tIII-ijo-67-03-05783/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tfn3-ijo-67-03-05783"><p>CRGs, cuproptosis-related genes; PCa, prostate cancer; FDX1, ferredoxin 1; DLAT, dihydrolipoamide S-acetyltransferase; DLD, dihydrolipoamide dehydrogenase; PDHA1, pyruvate dehydrogenase E1 subunit alpha 1; CDKN2A, cyclin-dependent kinase inhibitor 2A; DBT, dihydrolipoamide branched-chain transacylase E2; GLS, glutaminase; LIAS, lipoic acid synthase; STX3, syntaxin 3; CABLES2, Cdk5 and Abl enzyme substrate 2; E2F5, E2F transcription factor 5; RALA, RAS-like proto-oncogene A; POLE3, DNA polymerase epsilon 3; PRLR, prolactin receptor; DES, desmin; LECT2, lectin-like transcript 2; B4GALNT4, beta-1,4-galactosyltransferase 4; FAM83D, family with sequence similarity 83 member D; COL1A, collagen type I alpha; CHRM3, cholinergic receptor muscarinic 3; MYBPC1, myosin binding protein C 1; DFS, disease-free survival; OS, overall survival; CDI, cell death index; CRLs, cuproptosis-related long non-coding RNAs.</p></div></div></section><p>Irrespective of the trajectory of predictive modeling, research is focused on the development of novel molecular instruments for prognostic evaluation and clinical decision-making in PCa. Cuproptosis-based prognostic models exhibit efficacy in predicting outcomes of patients with PCa; however, the recurrence prediction mediated by CDI surpasses that of the cuproptosis-based prognostic models (<a href="#b123-ijo-67-03-05783" class="usa-link" aria-describedby="b123-ijo-67-03-05783">123</a>). CRLs obtained from bioinformatics analysis not only aid in the establishment of a prognostic prediction model for patients with PCa, but also the results of cellular experiments reveal that the knockdown of CRLs, particularly AC106820.5, may inhibit the proliferation, migration and invasive capabilities of PCa cells (<a href="#b127-ijo-67-03-05783" class="usa-link" aria-describedby="b127-ijo-67-03-05783">127</a>). Collectively, these data illustrate that bioinformatics analyses may be used to identify potential therapeutic targets in the treatment of PCa. Notably, the aforementioned models may also be used to predict responsiveness to immunotherapy, leading to the development of personalized treatment options that improve patient outcomes and quality of life.</p></section></section><section id="sec11"><h2 class="pmc_sec_title">5. Discussion</h2>
<p>The redox activity of copper represents a dual purpose in cellular viability; for example, it acts as a crucial cofactor for enzymes that facilitate vital physiological processes in cellular metabolism and may induce oxidative stress and cell death when present in excess (<a href="#b131-ijo-67-03-05783" class="usa-link" aria-describedby="b131-ijo-67-03-05783">131</a>,<a href="#b132-ijo-67-03-05783" class="usa-link" aria-describedby="b132-ijo-67-03-05783">132</a>). The initial discovery of cuproptosis elucidated the association between copper-induced cell death and mitochondrial metabolism, thus furthering investigations in copper biology and offering novel insights for future investigations into cell death pathways. In PCa, increased copper concentrations and a disruption of copper transporters result in the accumulation of copper ions within tumor cells, facilitating the initiation of cuproptosis. The activation of cuproptosis facilitates the elimination of surplus copper ions, mitigates cellular damage resulting from copper metabolism disorders and suppresses the proliferation, invasion and metastasis of PCa cells, thereby inhibiting tumor progression induced by copper metabolism disorders. However, further investigations are required to determine the specific underlying mechanisms.</p>
<p>In recent years, cuproptosis has become a novel focus within PCa research, demonstrating potential in various tumors to markedly impact the proliferation, invasion and metastasis of tumor cells. Despite novel insights into the role of cuproptosis in PCa, this field of study exhibits certain limitations. Cuproptosis may inhibit the progression of PCa; however, PCa requires elevated copper levels for its physiological functions. In addition, FDX1 expression in PCa cells remains low to prevent the initiation of cuproptosis. Androgens may enhance the transcriptional levels of CTR1, ATP7B and STEAP in PCa cells via androgen receptor activation, thereby increasing copper uptake and facilitating PCa progression (<a href="#b49-ijo-67-03-05783" class="usa-link" aria-describedby="b49-ijo-67-03-05783">49</a>). Moreover, the hypothesis regarding increased copper demand in PCa and the approaches to alleviate levels of toxicity remain ambiguous and the specific molecular mechanisms underlying cuproptosis have yet to be fully elucidated. Thus, further investigations should focus on the specific signaling pathways and regulatory mechanisms underlying this phenomenon. Notably, these processes may include the accumulation of copper ions in PCa cells, the functions of pivotal proteins and the activation of signaling pathways associated with the onset of cuproptosis. To date, previous research has focused on CRGs and CRLs and the use of bioinformatics analyses, predictive model development and <em>in vitro</em> experimentation. The aforementioned studies have primarily utilized public databases for analysis, which may result in limitations in the validity of studies, through large-scale clinical samples and a lack of investigation into clinical applications. Thus, further investigations should focus on the use of genetic analysis of clinical samples to validate prior findings and inform subsequent studies. Notably, the AlphaFold (<a href="https://deepmind.google/science/alphafold/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://deepmind.google/science/alphafold/</a>) suite of tools constitutes a robust, integrated platform for structural prediction. It is used to accurately predict the structures of proteins interacting with various biomolecules (<a href="#b133-ijo-67-03-05783" class="usa-link" aria-describedby="b133-ijo-67-03-05783">133</a>). Thus, the development of novel prediction models using AlphaFold 3 tools may further the understanding of PCa at the molecular level and aid in the identification of additional therapeutic targets. Further investigations into drug sensitivity may lead to the development of novel therapeutic targets, while analyses of immune cells inside the tumor microenvironment may clarify the role of cuproptosis in modulating their activity and the potential impact on tumor proliferation and metastasis. Moreover, a multidisciplinary research approach is required to elucidate the specific role of cuproptosis in PCa, thereby establishing a foundation for the advancement of novel therapies aimed at enhancing the prognosis and quality of life of patients.</p>
<p>In conclusion, the present review article demonstrated that cuproptosis may exhibit potential in the treatment of PCa. Notably, copper-based nanomedicines, as well as traditional copper ion carriers and chelators, may elicit more potent anti-tumor effects. Additional investigations into the transformation of conventional pharmaceuticals into nanoparticles, alongside additional clinical trials, may aid in the development of a novel therapeutic approach. However, these trials should be preceded by a comprehensive understanding of the mechanisms underlying copper metabolism and cuproptosis, aiming to determine distinct interactions between copper and the tumor microenvironment, as well as immune responses, which are essential for drug design and efficacy prediction. Notably, the identification of cuproptosis has prompted extensive investigations into novel treatment options for PCa and this newly recognized mechanism of regulatory cell death may contribute to theoretical advancements and practical implementations in the field.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The present study was supported by the National Natural Science Foundation of China (grant nos. 81503589, 81973866 and 82474520), the Natural Science Foundation of Sichuan Province (grant no. 2022NSFSC0684) and the Sichuan Provincial Administration of Traditional Chinese Medicine Science and Technology Research Special Fund Project (grant no. 2021ZD016).</p></section><section id="sec12"><h2 class="pmc_sec_title">Availability of data and materials</h2>
<p>Not applicable.</p></section><section id="sec13"><h2 class="pmc_sec_title">Authors' contributions</h2>
<p>ZL was responsible for writing the original draft, reviewing and editing, project administration, supervision and conceptualization. YC was responsible for writing the original draft, reviewing and editing, supervision and visualization. KZ was responsible for writing the original draft, supervision and conceptualization. ZC was responsible for writing the original draft and resources. YY was responsible for funding acquisition, supervision, project administration, writing, reviewing and editing. Data authentication is not applicable. All authors read and approved the final manuscript.</p></section><section id="sec14"><h2 class="pmc_sec_title">Ethics approval and consent to participate</h2>
<p>Not applicable.</p></section><section id="sec15"><h2 class="pmc_sec_title">Patient consent for publication</h2>
<p>Not applicable.</p></section><section id="sec16"><h2 class="pmc_sec_title">Competing interests</h2>
<p>The authors declare that they have no competing interests.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="b1-ijo-67-03-05783">
<span class="label">1.</span><cite>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660.</cite> [<a href="https://doi.org/10.3322/caac.21660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33538338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Global%20cancer%20statistics%202020:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries&amp;author=H%20Sung&amp;author=J%20Ferlay&amp;author=RL%20Siegel&amp;author=M%20Laversanne&amp;author=I%20Soerjomataram&amp;volume=71&amp;publication_year=2021&amp;pages=209-249&amp;pmid=33538338&amp;doi=10.3322/caac.21660&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b2-ijo-67-03-05783">
<span class="label">2.</span><cite>Siegel DA, O'Neil ME, Richards TB, Dowling NF, Weir HK. Prostate cancer incidence and survival, by stage and race/ethnicity - United States, 2001-2017. MMWR Morb Mortal Wkly Rep. 2020;69:1473–1480. doi: 10.15585/mmwr.mm6941a1.</cite> [<a href="https://doi.org/10.15585/mmwr.mm6941a1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7561091/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33056955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&amp;title=Prostate%20cancer%20incidence%20and%20survival,%20by%20stage%20and%20race/ethnicity%20-%20United%20States,%202001-2017&amp;author=DA%20Siegel&amp;author=ME%20O'Neil&amp;author=TB%20Richards&amp;author=NF%20Dowling&amp;author=HK%20Weir&amp;volume=69&amp;publication_year=2020&amp;pages=1473-1480&amp;pmid=33056955&amp;doi=10.15585/mmwr.mm6941a1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b3-ijo-67-03-05783">
<span class="label">3.</span><cite>Zhang Z, Garzotto M, Davis EW, II, Mori M, Stoller WA, Farris PE, Wong CP, Beaver LM, Thomas GV, Williams DE, et al.  Sulforaphane bioavailability and chemopreventive activity in men presenting for biopsy of the prostate gland: A Randomized controlled trial. Nutr Cancer. 2020;72:74–87. doi: 10.1080/01635581.2019.1619783.</cite> [<a href="https://doi.org/10.1080/01635581.2019.1619783" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8244813/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31155953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nutr%20Cancer&amp;title=Sulforaphane%20bioavailability%20and%20chemopreventive%20activity%20in%20men%20presenting%20for%20biopsy%20of%20the%20prostate%20gland:%20A%20Randomized%20controlled%20trial&amp;author=Z%20Zhang&amp;author=M%20Garzotto&amp;author=EW%20Davis&amp;author=M%20Mori&amp;author=WA%20Stoller&amp;volume=72&amp;publication_year=2020&amp;pages=74-87&amp;pmid=31155953&amp;doi=10.1080/01635581.2019.1619783&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b4-ijo-67-03-05783">
<span class="label">4.</span><cite>Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, De Santis M, Farolfi A, et al.  EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: Treatment of relapsing and metastatic prostate cancer. Eur Urol. 2024;86:164–182. doi: 10.1016/j.eururo.2024.04.010.</cite> [<a href="https://doi.org/10.1016/j.eururo.2024.04.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38688773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Urol&amp;title=EAU-EANM-ESTRO-ESUR-ISUP-SIOG%20guidelines%20on%20prostate%20cancer.%20Part%20II-2024%20update:%20Treatment%20of%20relapsing%20and%20metastatic%20prostate%20cancer&amp;author=D%20Tilki&amp;author=RCN%20van%20den%20Bergh&amp;author=E%20Briers&amp;author=T%20Van%20den%20Broeck&amp;author=O%20Brunckhorst&amp;volume=86&amp;publication_year=2024&amp;pages=164-182&amp;pmid=38688773&amp;doi=10.1016/j.eururo.2024.04.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b5-ijo-67-03-05783">
<span class="label">5.</span><cite>Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, De Santis M, Farolfi A, et al.  EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: Screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86:148–163. doi: 10.1016/j.eururo.2024.03.027.</cite> [<a href="https://doi.org/10.1016/j.eururo.2024.03.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38614820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Urol&amp;title=EAU-EANM-ESTRO-ESUR-ISUP-SIOG%20guidelines%20on%20prostate%20cancer-2024%20update.%20Part%20I:%20Screening,%20diagnosis,%20and%20local%20treatment%20with%20curative%20intent&amp;author=P%20Cornford&amp;author=RCN%20van%20den%20Bergh&amp;author=E%20Briers&amp;author=T%20Van%20den%20Broeck&amp;author=O%20Brunckhorst&amp;volume=86&amp;publication_year=2024&amp;pages=148-163&amp;pmid=38614820&amp;doi=10.1016/j.eururo.2024.03.027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b6-ijo-67-03-05783">
<span class="label">6.</span><cite>Gillessen S, Bossi A, Davis ID, de Bono J, Fizazi K, James ND, Mottet N, Shore N, Small E, Smith M, et al.  Management of patients with advanced prostate cancer. Part I: Intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment: Report of the advanced prostate cancer consensus conference 2022. Eur Urol. 2023;83:267–293. doi: 10.1016/j.eururo.2022.11.002.</cite> [<a href="https://doi.org/10.1016/j.eururo.2022.11.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7614721/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36494221/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Urol&amp;title=Management%20of%20patients%20with%20advanced%20prostate%20cancer.%20Part%20I:%20Intermediate-/high-risk%20and%20locally%20advanced%20disease,%20biochemical%20relapse,%20and%20side%20effects%20of%20hormonal%20treatment:%20Report%20of%20the%20advanced%20prostate%20cancer%20consensus%20conference%202022&amp;author=S%20Gillessen&amp;author=A%20Bossi&amp;author=ID%20Davis&amp;author=J%20de%20Bono&amp;author=K%20Fizazi&amp;volume=83&amp;publication_year=2023&amp;pages=267-293&amp;pmid=36494221&amp;doi=10.1016/j.eururo.2022.11.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b7-ijo-67-03-05783">
<span class="label">7.</span><cite>Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG. Prostate cancer. Lancet. 2021;398:1075–1090. doi: 10.1016/S0140-6736(21)00950-8.</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00950-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34370973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Prostate%20cancer&amp;author=S%20Sandhu&amp;author=CM%20Moore&amp;author=E%20Chiong&amp;author=H%20Beltran&amp;author=RG%20Bristow&amp;volume=398&amp;publication_year=2021&amp;pages=1075-1090&amp;pmid=34370973&amp;doi=10.1016/S0140-6736(21)00950-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b8-ijo-67-03-05783">
<span class="label">8.</span><cite>Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984;219:1–14. doi: 10.1042/bj2190001.</cite> [<a href="https://doi.org/10.1042/bj2190001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1153442/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6326753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20J&amp;title=Oxygen%20toxicity,%20oxygen%20radicals,%20transition%20metals%20and%20disease&amp;author=B%20Halliwell&amp;author=JM%20Gutteridge&amp;volume=219&amp;publication_year=1984&amp;pages=1-14&amp;pmid=6326753&amp;doi=10.1042/bj2190001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b9-ijo-67-03-05783">
<span class="label">9.</span><cite>Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, et al.  Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254–1261. doi: 10.1126/science.abf0529.</cite> [<a href="https://doi.org/10.1126/science.abf0529" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9273333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35298263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Copper%20induces%20cell%20death%20by%20targeting%20lipoylated%20TCA%20cycle%20proteins&amp;author=P%20Tsvetkov&amp;author=S%20Coy&amp;author=B%20Petrova&amp;author=M%20Dreishpoon&amp;author=A%20Verma&amp;volume=375&amp;publication_year=2022&amp;pages=1254-1261&amp;pmid=35298263&amp;doi=10.1126/science.abf0529&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b10-ijo-67-03-05783">
<span class="label">10.</span><cite>Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Frühbeck G, et al.  Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep. 2021;3:100322. doi: 10.1016/j.jhepr.2021.100322.</cite> [<a href="https://doi.org/10.1016/j.jhepr.2021.100322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8514420/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34693236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JHEP%20Rep&amp;title=Non-alcoholic%20fatty%20liver%20disease:%20A%20patient%20guideline&amp;author=SM%20Francque&amp;author=G%20Marchesini&amp;author=A%20Kautz&amp;author=M%20Walmsley&amp;author=R%20Dorner&amp;volume=3&amp;publication_year=2021&amp;pages=100322&amp;pmid=34693236&amp;doi=10.1016/j.jhepr.2021.100322&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b11-ijo-67-03-05783">
<span class="label">11.</span><cite>Mason KE. A conspectus of research on copper metabolism and requirements of man. J Nutr. 1979;109:1979–2066. doi: 10.1093/jn/109.11.1979.</cite> [<a href="https://doi.org/10.1093/jn/109.11.1979" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/387922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Nutr&amp;title=A%20conspectus%20of%20research%20on%20copper%20metabolism%20and%20requirements%20of%20man&amp;author=KE%20Mason&amp;volume=109&amp;publication_year=1979&amp;pages=1979-2066&amp;pmid=387922&amp;doi=10.1093/jn/109.11.1979&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b12-ijo-67-03-05783">
<span class="label">12.</span><cite>Dancis A, Roman DG, Anderson GJ, Hinnebusch AG, Klausner RD. Ferric reductase of Saccharomyces cerevisiae: molecular characterization, role in iron uptake, and transcriptional control by iron. Proc Natl Acad Sci USA. 1992;89:3869–3873. doi: 10.1073/pnas.89.9.3869.</cite> [<a href="https://doi.org/10.1073/pnas.89.9.3869" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC525592/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1570306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&amp;title=Ferric%20reductase%20of%20Saccharomyces%20cerevisiae:%20molecular%20characterization,%20role%20in%20iron%20uptake,%20and%20transcriptional%20control%20by%20iron&amp;author=A%20Dancis&amp;author=DG%20Roman&amp;author=GJ%20Anderson&amp;author=AG%20Hinnebusch&amp;author=RD%20Klausner&amp;volume=89&amp;publication_year=1992&amp;pages=3869-3873&amp;pmid=1570306&amp;doi=10.1073/pnas.89.9.3869&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b13-ijo-67-03-05783">
<span class="label">13.</span><cite>Georgatsou E, Mavrogiannis LA, Fragiadakis GS, Alexandraki D. The yeast Fre1p/Fre2p cupric reductases facilitate copper uptake and are regulated by the copper-modulated Mac1p activator. J Biol Chem. 1997;272:13786–13792. doi: 10.1074/jbc.272.21.13786.</cite> [<a href="https://doi.org/10.1074/jbc.272.21.13786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9153234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=The%20yeast%20Fre1p/Fre2p%20cupric%20reductases%20facilitate%20copper%20uptake%20and%20are%20regulated%20by%20the%20copper-modulated%20Mac1p%20activator&amp;author=E%20Georgatsou&amp;author=LA%20Mavrogiannis&amp;author=GS%20Fragiadakis&amp;author=D%20Alexandraki&amp;volume=272&amp;publication_year=1997&amp;pages=13786-13792&amp;pmid=9153234&amp;doi=10.1074/jbc.272.21.13786&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b14-ijo-67-03-05783">
<span class="label">14.</span><cite>Guan D, Zhao L, Shi X, Ma X, Chen Z. Copper in cancer: From pathogenesis to therapy. Biomed Pharmacother. 2023;163:114791. doi: 10.1016/j.biopha.2023.114791.</cite> [<a href="https://doi.org/10.1016/j.biopha.2023.114791" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37105071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Pharmacother&amp;title=Copper%20in%20cancer:%20From%20pathogenesis%20to%20therapy&amp;author=D%20Guan&amp;author=L%20Zhao&amp;author=X%20Shi&amp;author=X%20Ma&amp;author=Z%20Chen&amp;volume=163&amp;publication_year=2023&amp;pages=114791&amp;pmid=37105071&amp;doi=10.1016/j.biopha.2023.114791&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b15-ijo-67-03-05783">
<span class="label">15.</span><cite>Boyd SD, Ullrich MS, Skopp A, Winkler DD. Copper sources for Sod1 activation. Antioxidants (Basel) 2020;9:500. doi: 10.3390/antiox9060500.</cite> [<a href="https://doi.org/10.3390/antiox9060500" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7346115/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32517371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxidants%20(Basel)&amp;title=Copper%20sources%20for%20Sod1%20activation&amp;author=SD%20Boyd&amp;author=MS%20Ullrich&amp;author=A%20Skopp&amp;author=DD%20Winkler&amp;volume=9&amp;publication_year=2020&amp;pages=500&amp;pmid=32517371&amp;doi=10.3390/antiox9060500&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b16-ijo-67-03-05783">
<span class="label">16.</span><cite>Luza SC, Speisky HC. Liver copper storage and transport during development: Implications for cytotoxicity. Am J Clin Nutr. 1996;63:812S–820S. doi: 10.1093/ajcn/63.5.812.</cite> [<a href="https://doi.org/10.1093/ajcn/63.5.812" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8615368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Clin%20Nutr&amp;title=Liver%20copper%20storage%20and%20transport%20during%20development:%20Implications%20for%20cytotoxicity&amp;author=SC%20Luza&amp;author=HC%20Speisky&amp;volume=63&amp;publication_year=1996&amp;pages=812S-820S&amp;pmid=8615368&amp;doi=10.1093/ajcn/63.5.812&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b17-ijo-67-03-05783">
<span class="label">17.</span><cite>Pufahl RA, Singer CP, Peariso KL, Lin SJ, Schmidt PJ, Fahrni CJ, Culotta VC, Penner-Hahn JE, O'Halloran TV. Metal ion chaperone function of the soluble Cu(I) receptor Atx1. Science. 1997;278:853–856. doi: 10.1126/science.278.5339.853.</cite> [<a href="https://doi.org/10.1126/science.278.5339.853" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9346482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Metal%20ion%20chaperone%20function%20of%20the%20soluble%20Cu(I)%20receptor%20Atx1&amp;author=RA%20Pufahl&amp;author=CP%20Singer&amp;author=KL%20Peariso&amp;author=SJ%20Lin&amp;author=PJ%20Schmidt&amp;volume=278&amp;publication_year=1997&amp;pages=853-856&amp;pmid=9346482&amp;doi=10.1126/science.278.5339.853&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b18-ijo-67-03-05783">
<span class="label">18.</span><cite>Heaton DN, George GN, Garrison G, Winge DR. The mitochondrial copper metallochaperone Cox17 exists as an oligomeric, polycopper complex. Biochemistry. 2001;40:743–751. doi: 10.1021/bi002315x.</cite> [<a href="https://doi.org/10.1021/bi002315x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11170391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=The%20mitochondrial%20copper%20metallochaperone%20Cox17%20exists%20as%20an%20oligomeric,%20polycopper%20complex&amp;author=DN%20Heaton&amp;author=GN%20George&amp;author=G%20Garrison&amp;author=DR%20Winge&amp;volume=40&amp;publication_year=2001&amp;pages=743-751&amp;pmid=11170391&amp;doi=10.1021/bi002315x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b19-ijo-67-03-05783">
<span class="label">19.</span><cite>Gromadzka G, Tarnacka B, Flaga A, Adamczyk A. Copper dyshomeostasis in neurodegenerative diseases-therapeutic implications. Int J Mol Sci. 2020;21:9259. doi: 10.3390/ijms21239259.</cite> [<a href="https://doi.org/10.3390/ijms21239259" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7730516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33291628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Copper%20dyshomeostasis%20in%20neurodegenerative%20diseases-therapeutic%20implications&amp;author=G%20Gromadzka&amp;author=B%20Tarnacka&amp;author=A%20Flaga&amp;author=A%20Adamczyk&amp;volume=21&amp;publication_year=2020&amp;pages=9259&amp;pmid=33291628&amp;doi=10.3390/ijms21239259&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b20-ijo-67-03-05783">
<span class="label">20.</span><cite>La Fontaine S, Mercer JFB. Trafficking of the copper-ATPases, ATP7A and ATP7B: Role in copper homeostasis. Arch Biochem Biophys. 2007;463:149–167. doi: 10.1016/j.abb.2007.04.021.</cite> [<a href="https://doi.org/10.1016/j.abb.2007.04.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17531189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Biochem%20Biophys&amp;title=Trafficking%20of%20the%20copper-ATPases,%20ATP7A%20and%20ATP7B:%20Role%20in%20copper%20homeostasis&amp;author=S%20La%20Fontaine&amp;author=JFB%20Mercer&amp;volume=463&amp;publication_year=2007&amp;pages=149-167&amp;pmid=17531189&amp;doi=10.1016/j.abb.2007.04.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b21-ijo-67-03-05783">
<span class="label">21.</span><cite>Lutsenko S, LeShane ES, Shinde U. Biochemical basis of regulation of human copper-transporting ATPases. Arch Biochem Biophys. 2007;463:134–148. doi: 10.1016/j.abb.2007.04.013.</cite> [<a href="https://doi.org/10.1016/j.abb.2007.04.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2025638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17562324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Biochem%20Biophys&amp;title=Biochemical%20basis%20of%20regulation%20of%20human%20copper-transporting%20ATPases&amp;author=S%20Lutsenko&amp;author=ES%20LeShane&amp;author=U%20Shinde&amp;volume=463&amp;publication_year=2007&amp;pages=134-148&amp;pmid=17562324&amp;doi=10.1016/j.abb.2007.04.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b22-ijo-67-03-05783">
<span class="label">22.</span><cite>Lutsenko S, Bhattacharjee A, Hubbard AL. Copper handling machinery of the brain. Metallomics. 2010;2:596–608. doi: 10.1039/c0mt00006j.</cite> [<a href="https://doi.org/10.1039/c0mt00006j" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21072351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metallomics&amp;title=Copper%20handling%20machinery%20of%20the%20brain&amp;author=S%20Lutsenko&amp;author=A%20Bhattacharjee&amp;author=AL%20Hubbard&amp;volume=2&amp;publication_year=2010&amp;pages=596-608&amp;pmid=21072351&amp;doi=10.1039/c0mt00006j&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b23-ijo-67-03-05783">
<span class="label">23.</span><cite>Lutsenko S. Copper trafficking to the secretory pathway. Metallomics. 2016;8:84–852. doi: 10.1039/C6MT00176A.</cite> [<a href="https://doi.org/10.1039/C6MT00176A" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5548098/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27603756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metallomics&amp;title=Copper%20trafficking%20to%20the%20secretory%20pathway&amp;author=S%20Lutsenko&amp;volume=8&amp;publication_year=2016&amp;pages=84-852&amp;pmid=27603756&amp;doi=10.1039/C6MT00176A&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b24-ijo-67-03-05783">
<span class="label">24.</span><cite>Csiszar K. Lysyl oxidases: A novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol. 2001;70:1–32. doi: 10.1016/S0079-6603(01)70012-8.</cite> [<a href="https://doi.org/10.1016/S0079-6603(01)70012-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11642359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prog%20Nucleic%20Acid%20Res%20Mol%20Biol&amp;title=Lysyl%20oxidases:%20A%20novel%20multifunctional%20amine%20oxidase%20family&amp;author=K%20Csiszar&amp;volume=70&amp;publication_year=2001&amp;pages=1-32&amp;pmid=11642359&amp;doi=10.1016/S0079-6603(01)70012-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b25-ijo-67-03-05783">
<span class="label">25.</span><cite>Pierson H, Yang H, Lutsenko S. Copper transport and disease: What can we learn from organoids? Annu Rev Nutr. 2019;39:75–94. doi: 10.1146/annurev-nutr-082018-124242.</cite> [<a href="https://doi.org/10.1146/annurev-nutr-082018-124242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7065453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31150593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Nutr&amp;title=Copper%20transport%20and%20disease:%20What%20can%20we%20learn%20from%20organoids?&amp;author=H%20Pierson&amp;author=H%20Yang&amp;author=S%20Lutsenko&amp;volume=39&amp;publication_year=2019&amp;pages=75-94&amp;pmid=31150593&amp;doi=10.1146/annurev-nutr-082018-124242&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b26-ijo-67-03-05783">
<span class="label">26.</span><cite>Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Tar. 2022;7:378. doi: 10.1038/s41392-022-01229-y.</cite> [<a href="https://doi.org/10.1038/s41392-022-01229-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9681860/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36414625/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduct%20Tar&amp;title=Copper%20homeostasis%20and%20cuproptosis%20in%20health%20and%20disease&amp;author=L%20Chen&amp;author=J%20Min&amp;author=F%20Wang&amp;volume=7&amp;publication_year=2022&amp;pages=378&amp;pmid=36414625&amp;doi=10.1038/s41392-022-01229-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b27-ijo-67-03-05783">
<span class="label">27.</span><cite>Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology. 2003;189:147–163. doi: 10.1016/S0300-483X(03)00159-8.</cite> [<a href="https://doi.org/10.1016/S0300-483X(03)00159-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12821289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicology&amp;title=Copper%20toxicity,%20oxidative%20stress,%20and%20antioxidant%20nutrients&amp;author=LM%20Gaetke&amp;author=CK%20Chow&amp;volume=189&amp;publication_year=2003&amp;pages=147-163&amp;pmid=12821289&amp;doi=10.1016/S0300-483X(03)00159-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b28-ijo-67-03-05783">
<span class="label">28.</span><cite>Wang Z, Jin D, Zhou S, Dong N, Ji Y, An P, Wang J, Luo Y, Luo J. Regulatory roles of copper metabolism and cuproptosis in human cancers. Front Oncol. 2023;13:1123420. doi: 10.3389/fonc.2023.1123420.</cite> [<a href="https://doi.org/10.3389/fonc.2023.1123420" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10076572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37035162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Regulatory%20roles%20of%20copper%20metabolism%20and%20cuproptosis%20in%20human%20cancers&amp;author=Z%20Wang&amp;author=D%20Jin&amp;author=S%20Zhou&amp;author=N%20Dong&amp;author=Y%20Ji&amp;volume=13&amp;publication_year=2023&amp;pages=1123420&amp;pmid=37035162&amp;doi=10.3389/fonc.2023.1123420&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b29-ijo-67-03-05783">
<span class="label">29.</span><cite>Tang D, Chen X, Kroemer G. Cuproptosis: A copper-triggered modality of mitochondrial cell death. Cell Res. 2022;32:417–418. doi: 10.1038/s41422-022-00653-7.</cite> [<a href="https://doi.org/10.1038/s41422-022-00653-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9061796/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35354936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Res&amp;title=Cuproptosis:%20A%20copper-triggered%20modality%20of%20mitochondrial%20cell%20death&amp;author=D%20Tang&amp;author=X%20Chen&amp;author=G%20Kroemer&amp;volume=32&amp;publication_year=2022&amp;pages=417-418&amp;pmid=35354936&amp;doi=10.1038/s41422-022-00653-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b30-ijo-67-03-05783">
<span class="label">30.</span><cite>Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, Feng T, Cui Z, Zhu T, Li Y, et al.  Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14:6523. doi: 10.1038/s41467-023-42025-8.</cite> [<a href="https://doi.org/10.1038/s41467-023-42025-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10589265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37863889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Lactylation%20of%20METTL16%20promotes%20cuproptosis%20via%20m(6)A-modification%20on%20FDX1%20mRNA%20in%20gastric%20cancer&amp;author=L%20Sun&amp;author=Y%20Zhang&amp;author=B%20Yang&amp;author=S%20Sun&amp;author=P%20Zhang&amp;volume=14&amp;publication_year=2023&amp;pages=6523&amp;pmid=37863889&amp;doi=10.1038/s41467-023-42025-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b31-ijo-67-03-05783">
<span class="label">31.</span><cite>Xie J, Yang Y, Gao Y, He J. Cuproptosis: Mechanisms and links with cancers. Mol Cancer. 2023;22:46. doi: 10.1186/s12943-023-01732-y.</cite> [<a href="https://doi.org/10.1186/s12943-023-01732-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9990368/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36882769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer&amp;title=Cuproptosis:%20Mechanisms%20and%20links%20with%20cancers&amp;author=J%20Xie&amp;author=Y%20Yang&amp;author=Y%20Gao&amp;author=J%20He&amp;volume=22&amp;publication_year=2023&amp;pages=46&amp;pmid=36882769&amp;doi=10.1186/s12943-023-01732-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b32-ijo-67-03-05783">
<span class="label">32.</span><cite>Feng Q, Huo C, Wang M, Huang H, Zheng X, Xie M. Research progress on cuproptosis in cancer. Front Pharmacol. 2024;15:1290592. doi: 10.3389/fphar.2024.1290592.</cite> [<a href="https://doi.org/10.3389/fphar.2024.1290592" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10864558/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38357312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Research%20progress%20on%20cuproptosis%20in%20cancer&amp;author=Q%20Feng&amp;author=C%20Huo&amp;author=M%20Wang&amp;author=H%20Huang&amp;author=X%20Zheng&amp;volume=15&amp;publication_year=2024&amp;pages=1290592&amp;pmid=38357312&amp;doi=10.3389/fphar.2024.1290592&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b33-ijo-67-03-05783">
<span class="label">33.</span><cite>Liu WQ, Lin WR, Yan L, Xu WH, Yang J. Copper homeostasis and cuproptosis in cancer immunity and therapy. Immunol Rev. 2024;321:211–227. doi: 10.1111/imr.13276.</cite> [<a href="https://doi.org/10.1111/imr.13276" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37715546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunol%20Rev&amp;title=Copper%20homeostasis%20and%20cuproptosis%20in%20cancer%20immunity%20and%20therapy&amp;author=WQ%20Liu&amp;author=WR%20Lin&amp;author=L%20Yan&amp;author=WH%20Xu&amp;author=J%20Yang&amp;volume=321&amp;publication_year=2024&amp;pages=211-227&amp;pmid=37715546&amp;doi=10.1111/imr.13276&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b34-ijo-67-03-05783">
<span class="label">34.</span><cite>Nowell CS, Radtke F. Notch as a tumour suppressor. Nat Rev Cancer. 2017;17:145–159. doi: 10.1038/nrc.2016.145.</cite> [<a href="https://doi.org/10.1038/nrc.2016.145" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28154375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Notch%20as%20a%20tumour%20suppressor&amp;author=CS%20Nowell&amp;author=F%20Radtke&amp;volume=17&amp;publication_year=2017&amp;pages=145-159&amp;pmid=28154375&amp;doi=10.1038/nrc.2016.145&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b35-ijo-67-03-05783">
<span class="label">35.</span><cite>Xie F, Peng F. Reduction in copper uptake and inhibition of prostate cancer cell proliferation by novel steroid-based compounds. Anticancer Res. 2021;41:5953–5958. doi: 10.21873/anticanres.15414.</cite> [<a href="https://doi.org/10.21873/anticanres.15414" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34848449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer%20Res&amp;title=Reduction%20in%20copper%20uptake%20and%20inhibition%20of%20prostate%20cancer%20cell%20proliferation%20by%20novel%20steroid-based%20compounds&amp;author=F%20Xie&amp;author=F%20Peng&amp;volume=41&amp;publication_year=2021&amp;pages=5953-5958&amp;pmid=34848449&amp;doi=10.21873/anticanres.15414&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b36-ijo-67-03-05783">
<span class="label">36.</span><cite>Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11:107. doi: 10.1186/s13045-018-0645-x.</cite> [<a href="https://doi.org/10.1186/s13045-018-0645-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6108115/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30139373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hematol%20Oncol&amp;title=The%20roles%20of%20metallothioneins%20in%20carcinogenesis&amp;author=M%20Si&amp;author=J%20Lang&amp;volume=11&amp;publication_year=2018&amp;pages=107&amp;pmid=30139373&amp;doi=10.1186/s13045-018-0645-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b37-ijo-67-03-05783">
<span class="label">37.</span><cite>Baldari S, Di Rocco G, Toietta G. Current biomedical use of copper chelation therapy. Int J Mol Sci. 2020;21:1069. doi: 10.3390/ijms21031069.</cite> [<a href="https://doi.org/10.3390/ijms21031069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7037088/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32041110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Current%20biomedical%20use%20of%20copper%20chelation%20therapy&amp;author=S%20Baldari&amp;author=G%20Di%20Rocco&amp;author=G%20Toietta&amp;volume=21&amp;publication_year=2020&amp;pages=1069&amp;pmid=32041110&amp;doi=10.3390/ijms21031069&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b38-ijo-67-03-05783">
<span class="label">38.</span><cite>Ilyechova EY, Bonaldi E, Orlov IA, Skomorokhova EA, Puchkova LV, Broggini M. CRISP-R/Cas9 mediated deletion of copper transport genes CTR1 and DMT1 in NSCLC cell line H1299. Biological and pharmacological consequences. Cells. 2019;8:322. doi: 10.3390/cells8040322.</cite> [<a href="https://doi.org/10.3390/cells8040322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6523758/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30959888/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=CRISP-R/Cas9%20mediated%20deletion%20of%20copper%20transport%20genes%20CTR1%20and%20DMT1%20in%20NSCLC%20cell%20line%20H1299.%20Biological%20and%20pharmacological%20consequences&amp;author=EY%20Ilyechova&amp;author=E%20Bonaldi&amp;author=IA%20Orlov&amp;author=EA%20Skomorokhova&amp;author=LV%20Puchkova&amp;volume=8&amp;publication_year=2019&amp;pages=322&amp;pmid=30959888&amp;doi=10.3390/cells8040322&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b39-ijo-67-03-05783">
<span class="label">39.</span><cite>Shao S, Si J, Shen Y. Copper as the target for anticancer nanomedicine. Adv Ther. 2019;2 doi: 10.1002/adtp.201800147.</cite> [<a href="https://doi.org/10.1002/adtp.201800147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Ther&amp;title=Copper%20as%20the%20target%20for%20anticancer%20nanomedicine&amp;author=S%20Shao&amp;author=J%20Si&amp;author=Y%20Shen&amp;volume=2&amp;publication_year=2019&amp;doi=10.1002/adtp.201800147&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b40-ijo-67-03-05783">
<span class="label">40.</span><cite>Li Y. Copper homeostasis: Emerging target for cancer treatment. IUBMB Life. 2020;72:1900–1908. doi: 10.1002/iub.2341.</cite> [<a href="https://doi.org/10.1002/iub.2341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32599675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IUBMB%20Life&amp;title=Copper%20homeostasis:%20Emerging%20target%20for%20cancer%20treatment&amp;author=Y%20Li&amp;volume=72&amp;publication_year=2020&amp;pages=1900-1908&amp;pmid=32599675&amp;doi=10.1002/iub.2341&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b41-ijo-67-03-05783">
<span class="label">41.</span><cite>Lelièvre P, Sancey L, Coll JL, Deniaud A, Busser B. The multifaceted roles of copper in cancer: A trace metal element with dysregulated metabolism, but also a target or a bullet for therapy. Cancers (Basel) 2020;12:3594. doi: 10.3390/cancers12123594.</cite> [<a href="https://doi.org/10.3390/cancers12123594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7760327/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33271772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=The%20multifaceted%20roles%20of%20copper%20in%20cancer:%20A%20trace%20metal%20element%20with%20dysregulated%20metabolism,%20but%20also%20a%20target%20or%20a%20bullet%20for%20therapy&amp;author=P%20Leli%C3%A8vre&amp;author=L%20Sancey&amp;author=JL%20Coll&amp;author=A%20Deniaud&amp;author=B%20Busser&amp;volume=12&amp;publication_year=2020&amp;pages=3594&amp;pmid=33271772&amp;doi=10.3390/cancers12123594&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b42-ijo-67-03-05783">
<span class="label">42.</span><cite>Li S, Zhang J, Yang H, Wu C, Dang X, Liu Y. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition. Sci Rep. 2015;5:12410. doi: 10.1038/srep12410.</cite> [<a href="https://doi.org/10.1038/srep12410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4502431/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26174737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Copper%20depletion%20inhibits%20CoCl2-induced%20aggressive%20phenotype%20of%20MCF-7%20cells%20via%20downregulation%20of%20HIF-1%20and%20inhibition%20of%20Snail/Twist-mediated%20epithelial-mesenchymal%20transition&amp;author=S%20Li&amp;author=J%20Zhang&amp;author=H%20Yang&amp;author=C%20Wu&amp;author=X%20Dang&amp;volume=5&amp;publication_year=2015&amp;pages=12410&amp;pmid=26174737&amp;doi=10.1038/srep12410&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b43-ijo-67-03-05783">
<span class="label">43.</span><cite>Gao X, Zhao H, Liu J, Wang M, Dai Z, Hao W, Wang Y, Wang X, Zhang M, Liu P, et al.  Enzalutamide sensitizes castration-resistant prostate cancer to copper-mediated cell death. Adv Sci (Weinh) 2024;11:e2401396. doi: 10.1002/advs.202401396.</cite> [<a href="https://doi.org/10.1002/advs.202401396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11321675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38859590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Sci%20(Weinh)&amp;title=Enzalutamide%20sensitizes%20castration-resistant%20prostate%20cancer%20to%20copper-mediated%20cell%20death&amp;author=X%20Gao&amp;author=H%20Zhao&amp;author=J%20Liu&amp;author=M%20Wang&amp;author=Z%20Dai&amp;volume=11&amp;publication_year=2024&amp;pages=e2401396&amp;pmid=38859590&amp;doi=10.1002/advs.202401396&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b44-ijo-67-03-05783">
<span class="label">44.</span><cite>Wang Y, Chen Y, Zhang J, Yang Y, Fleishman JS, Wang Y, Wang J, Chen J, Li Y, Wang H. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance. Drug Resist Update. 2024;72:101018. doi: 10.1016/j.drup.2023.101018.</cite> [<a href="https://doi.org/10.1016/j.drup.2023.101018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37979442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Resist%20Update&amp;title=Cuproptosis:%20A%20novel%20therapeutic%20target%20for%20overcoming%20cancer%20drug%20resistance&amp;author=Y%20Wang&amp;author=Y%20Chen&amp;author=J%20Zhang&amp;author=Y%20Yang&amp;author=JS%20Fleishman&amp;volume=72&amp;publication_year=2024&amp;pages=101018&amp;pmid=37979442&amp;doi=10.1016/j.drup.2023.101018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b45-ijo-67-03-05783">
<span class="label">45.</span><cite>Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, Dou QP, Franz KJ, Gohil VM, Gupta S, et al.  Connecting copper and cancer: From transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22:102–113. doi: 10.1038/s41568-021-00417-2.</cite> [<a href="https://doi.org/10.1038/s41568-021-00417-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8810673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34764459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Connecting%20copper%20and%20cancer:%20From%20transition%20metal%20signalling%20to%20metalloplasia&amp;author=EJ%20Ge&amp;author=AI%20Bush&amp;author=A%20Casini&amp;author=PA%20Cobine&amp;author=JR%20Cross&amp;volume=22&amp;publication_year=2022&amp;pages=102-113&amp;pmid=34764459&amp;doi=10.1038/s41568-021-00417-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b46-ijo-67-03-05783">
<span class="label">46.</span><cite>Stanislawska IJ, Figat R, Kiss AK, Bobrowska-Korczak B. Essential elements and isoflavonoids in the prevention of prostate cancer. Nutrients. 2022;14:1225. doi: 10.3390/nu14061225.</cite> [<a href="https://doi.org/10.3390/nu14061225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8949525/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35334882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nutrients&amp;title=Essential%20elements%20and%20isoflavonoids%20in%20the%20prevention%20of%20prostate%20cancer&amp;author=IJ%20Stanislawska&amp;author=R%20Figat&amp;author=AK%20Kiss&amp;author=B%20Bobrowska-Korczak&amp;volume=14&amp;publication_year=2022&amp;pages=1225&amp;pmid=35334882&amp;doi=10.3390/nu14061225&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b47-ijo-67-03-05783">
<span class="label">47.</span><cite>Cater MA, Haupt Y. Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): Therapeutic indication for prostate cancer. Biochem J. 2011;436:481–491. doi: 10.1042/BJ20110123.</cite> [<a href="https://doi.org/10.1042/BJ20110123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21426304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20J&amp;title=Clioquinol%20induces%20cytoplasmic%20clearance%20of%20the%20X-linked%20inhibitor%20of%20apoptosis%20protein%20(XIAP):%20Therapeutic%20indication%20for%20prostate%20cancer&amp;author=MA%20Cater&amp;author=Y%20Haupt&amp;volume=436&amp;publication_year=2011&amp;pages=481-491&amp;pmid=21426304&amp;doi=10.1042/BJ20110123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b48-ijo-67-03-05783">
<span class="label">48.</span><cite>Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP, Dou QP. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Res. 2007;67:1636–1644. doi: 10.1158/0008-5472.CAN-06-3546.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-06-3546" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17308104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Clioquinol,%20a%20therapeutic%20agent%20for%20Alzheimer's%20disease,%20has%20proteasome-inhibitory,%20androgen%20receptor-suppressing,%20apoptosis-inducing,%20and%20antitumor%20activities%20in%20human%20prostate%20cancer%20cells%20and%20xenografts&amp;author=D%20Chen&amp;author=QC%20Cui&amp;author=H%20Yang&amp;author=RA%20Barrea&amp;author=FH%20Sarkar&amp;volume=67&amp;publication_year=2007&amp;pages=1636-1644&amp;pmid=17308104&amp;doi=10.1158/0008-5472.CAN-06-3546&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b49-ijo-67-03-05783">
<span class="label">49.</span><cite>Safi R, Nelson ER, Chitneni SK, Franz KJ, George DJ, Zalutsky MR, McDonnell DP. Copper signaling axis as a target for prostate cancer therapeutics. Cancer Res. 2014;74:5819–5831. doi: 10.1158/0008-5472.CAN-13-3527.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-13-3527" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4203427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25320179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Copper%20signaling%20axis%20as%20a%20target%20for%20prostate%20cancer%20therapeutics&amp;author=R%20Safi&amp;author=ER%20Nelson&amp;author=SK%20Chitneni&amp;author=KJ%20Franz&amp;author=DJ%20George&amp;volume=74&amp;publication_year=2014&amp;pages=5819-5831&amp;pmid=25320179&amp;doi=10.1158/0008-5472.CAN-13-3527&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b50-ijo-67-03-05783">
<span class="label">50.</span><cite>Cai H, Wu JS, Muzik O, Hsieh JT, Lee RJ, Peng F. Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer. J Nucl Med. 2014;55:622–628. doi: 10.2967/jnumed.113.126979.</cite> [<a href="https://doi.org/10.2967/jnumed.113.126979" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4600613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24639459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Nucl%20Med&amp;title=Reduced%2064Cu%20uptake%20and%20tumor%20growth%20inhibition%20by%20knockdown%20of%20human%20copper%20transporter%201%20in%20xenograft%20mouse%20model%20of%20prostate%20cancer&amp;author=H%20Cai&amp;author=JS%20Wu&amp;author=O%20Muzik&amp;author=JT%20Hsieh&amp;author=RJ%20Lee&amp;volume=55&amp;publication_year=2014&amp;pages=622-628&amp;pmid=24639459&amp;doi=10.2967/jnumed.113.126979&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b51-ijo-67-03-05783">
<span class="label">51.</span><cite>Saleh SAK, Adly HM, Abdelkhaliq AA, Nassir AM. Serum levels of selenium, zinc, copper, manganese, and iron in prostate cancer patients. Curr Urol. 2020;14:44–49. doi: 10.1159/000499261.</cite> [<a href="https://doi.org/10.1159/000499261" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7206590/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32398996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Urol&amp;title=Serum%20levels%20of%20selenium,%20zinc,%20copper,%20manganese,%20and%20iron%20in%20prostate%20cancer%20patients&amp;author=SAK%20Saleh&amp;author=HM%20Adly&amp;author=AA%20Abdelkhaliq&amp;author=AM%20Nassir&amp;volume=14&amp;publication_year=2020&amp;pages=44-49&amp;pmid=32398996&amp;doi=10.1159/000499261&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b52-ijo-67-03-05783">
<span class="label">52.</span><cite>Kaba M, Pirincci N, Yuksel MB, Gecit I, Gunes M, Ozveren H, Eren H, Demir H. Serum levels of trace elements in patients with prostate cancer. Asian Pac J Cancer Prev. 2014;15:2625–2629. doi: 10.7314/APJCP.2014.15.6.2625.</cite> [<a href="https://doi.org/10.7314/APJCP.2014.15.6.2625" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24761874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Pac%20J%20Cancer%20Prev&amp;title=Serum%20levels%20of%20trace%20elements%20in%20patients%20with%20prostate%20cancer&amp;author=M%20Kaba&amp;author=N%20Pirincci&amp;author=MB%20Yuksel&amp;author=I%20Gecit&amp;author=M%20Gunes&amp;volume=15&amp;publication_year=2014&amp;pages=2625-2629&amp;pmid=24761874&amp;doi=10.7314/APJCP.2014.15.6.2625&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b53-ijo-67-03-05783">
<span class="label">53.</span><cite>Ozmen H, Erulas FA, Karatas F, Cukurovali A, Yalcin O. Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer. Clin Chem Lab Med. 2006;44:175–179. doi: 10.1515/CCLM.2006.032.</cite> [<a href="https://doi.org/10.1515/CCLM.2006.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16475903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem%20Lab%20Med&amp;title=Comparison%20of%20the%20concentration%20of%20trace%20metals%20(Ni,%20Zn,%20Co,%20Cu%20and%20Se),%20Fe,%20vitamins%20A,%20C%20and%20E,%20and%20lipid%20peroxidation%20in%20patients%20with%20prostate%20cancer&amp;author=H%20Ozmen&amp;author=FA%20Erulas&amp;author=F%20Karatas&amp;author=A%20Cukurovali&amp;author=O%20Yalcin&amp;volume=44&amp;publication_year=2006&amp;pages=175-179&amp;pmid=16475903&amp;doi=10.1515/CCLM.2006.032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b54-ijo-67-03-05783">
<span class="label">54.</span><cite>Wu J, He J, Liu Z, Zhu X, Li Z, Chen A, Lu J. Cuproptosis: Mechanism, role, and advances in urological malignancies. Med Res Rev. 2024;44:1662–1682. doi: 10.1002/med.22025.</cite> [<a href="https://doi.org/10.1002/med.22025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38299968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med%20Res%20Rev&amp;title=Cuproptosis:%20Mechanism,%20role,%20and%20advances%20in%20urological%20malignancies&amp;author=J%20Wu&amp;author=J%20He&amp;author=Z%20Liu&amp;author=X%20Zhu&amp;author=Z%20Li&amp;volume=44&amp;publication_year=2024&amp;pages=1662-1682&amp;pmid=38299968&amp;doi=10.1002/med.22025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b55-ijo-67-03-05783">
<span class="label">55.</span><cite>Baszuk P, Marciniak W, Derkacz R, Jakubowska A, Cybulski C, Gronwald J, Dębniak T, Huzarski T, Białkowska K, Pietrzak S, et al.  Blood copper levels and the occurrence of colorectal cancer in Poland. Biomedicines. 2021;9:1628. doi: 10.3390/biomedicines9111628.</cite> [<a href="https://doi.org/10.3390/biomedicines9111628" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8615693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34829856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicines&amp;title=Blood%20copper%20levels%20and%20the%20occurrence%20of%20colorectal%20cancer%20in%20Poland&amp;author=P%20Baszuk&amp;author=W%20Marciniak&amp;author=R%20Derkacz&amp;author=A%20Jakubowska&amp;author=C%20Cybulski&amp;volume=9&amp;publication_year=2021&amp;pages=1628&amp;pmid=34829856&amp;doi=10.3390/biomedicines9111628&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b56-ijo-67-03-05783">
<span class="label">56.</span><cite>Baltaci AK, Dundar TK, Aksoy F, Mogulkoc R. Changes in the serum levels of trace elements before and after the operation in thyroid cancer patients. Biol Trace Elem Res. 2017;175:57–64. doi: 10.1007/s12011-016-0768-2.</cite> [<a href="https://doi.org/10.1007/s12011-016-0768-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27263537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biol%20Trace%20Elem%20Res&amp;title=Changes%20in%20the%20serum%20levels%20of%20trace%20elements%20before%20and%20after%20the%20operation%20in%20thyroid%20cancer%20patients&amp;author=AK%20Baltaci&amp;author=TK%20Dundar&amp;author=F%20Aksoy&amp;author=R%20Mogulkoc&amp;volume=175&amp;publication_year=2017&amp;pages=57-64&amp;pmid=27263537&amp;doi=10.1007/s12011-016-0768-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b57-ijo-67-03-05783">
<span class="label">57.</span><cite>Jin Y, Zhang C, Xu H, Xue S, Wang Y, Hou Y, Kong Y, Xu Y. Combined effects of serum trace metals and polymorphisms of CYP1A1 or GSTM1 on non-small cell lung cancer: A hospital based case-control study in China. Cancer Epidemiol. 2011;35:182–187. doi: 10.1016/j.canep.2010.06.004.</cite> [<a href="https://doi.org/10.1016/j.canep.2010.06.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20638923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol&amp;title=Combined%20effects%20of%20serum%20trace%20metals%20and%20polymorphisms%20of%20CYP1A1%20or%20GSTM1%20on%20non-small%20cell%20lung%20cancer:%20A%20hospital%20based%20case-control%20study%20in%20China&amp;author=Y%20Jin&amp;author=C%20Zhang&amp;author=H%20Xu&amp;author=S%20Xue&amp;author=Y%20Wang&amp;volume=35&amp;publication_year=2011&amp;pages=182-187&amp;pmid=20638923&amp;doi=10.1016/j.canep.2010.06.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b58-ijo-67-03-05783">
<span class="label">58.</span><cite>Aubert L, Nandagopal N, Steinhart Z, Lavoie G, Nourreddine S, Berman J, Saba-El-Leil MK, Papadopoli D, Lin S, Hart T, et al.  Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nat Commun. 2020;11:3701. doi: 10.1038/s41467-020-17549-y.</cite> [<a href="https://doi.org/10.1038/s41467-020-17549-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7381612/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32709883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Copper%20bioavailability%20is%20a%20KRAS-specific%20vulnerability%20in%20colorectal%20cancer&amp;author=L%20Aubert&amp;author=N%20Nandagopal&amp;author=Z%20Steinhart&amp;author=G%20Lavoie&amp;author=S%20Nourreddine&amp;volume=11&amp;publication_year=2020&amp;pages=3701&amp;pmid=32709883&amp;doi=10.1038/s41467-020-17549-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b59-ijo-67-03-05783">
<span class="label">59.</span><cite>Lener MR, Scott RJ, Wiechowska-Kozlowska A, Serrano-Fernández P, Baszuk P, Jaworska-Bieniek K, Sukiennicki G, Marciniak W, Muszyńska M, Kładny J, et al.  Serum concentrations of selenium and copper in patients diagnosed with pancreatic cancer. Cancer Res Treat. 2016;48:1056–1064. doi: 10.4143/crt.2015.282.</cite> [<a href="https://doi.org/10.4143/crt.2015.282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4946347/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26727715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res%20Treat&amp;title=Serum%20concentrations%20of%20selenium%20and%20copper%20in%20patients%20diagnosed%20with%20pancreatic%20cancer&amp;author=MR%20Lener&amp;author=RJ%20Scott&amp;author=A%20Wiechowska-Kozlowska&amp;author=P%20Serrano-Fern%C3%A1ndez&amp;author=P%20Baszuk&amp;volume=48&amp;publication_year=2016&amp;pages=1056-1064&amp;pmid=26727715&amp;doi=10.4143/crt.2015.282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b60-ijo-67-03-05783">
<span class="label">60.</span><cite>Pavithra V, Sathisha TG, Kasturi K, Mallika DS, Amos SJ, Ragunatha S. Serum levels of metal ions in female patients with breast cancer. J Clin Diagn Res. 2015;9:BC25–BC27. doi: 10.7860/JCDR/2015/11627.5476.</cite> [<a href="https://doi.org/10.7860/JCDR/2015/11627.5476" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4347069/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25737978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Diagn%20Res&amp;title=Serum%20levels%20of%20metal%20ions%20in%20female%20patients%20with%20breast%20cancer&amp;author=V%20Pavithra&amp;author=TG%20Sathisha&amp;author=K%20Kasturi&amp;author=DS%20Mallika&amp;author=SJ%20Amos&amp;volume=9&amp;publication_year=2015&amp;pages=BC25-BC27&amp;pmid=25737978&amp;doi=10.7860/JCDR/2015/11627.5476&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b61-ijo-67-03-05783">
<span class="label">61.</span><cite>Yang L, Zhang Y, Wang Y, Jiang P, Liu F, Feng N. Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis. Front Pharmacol. 2022;13:938134. doi: 10.3389/fphar.2022.938134.</cite> [<a href="https://doi.org/10.3389/fphar.2022.938134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9532935/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36210836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Ferredoxin%201%20is%20a%20cuproptosis-key%20gene%20responsible%20for%20tumor%20immunity%20and%20drug%20sensitivity:%20A%20pan-cancer%20analysis&amp;author=L%20Yang&amp;author=Y%20Zhang&amp;author=Y%20Wang&amp;author=P%20Jiang&amp;author=F%20Liu&amp;volume=13&amp;publication_year=2022&amp;pages=938134&amp;pmid=36210836&amp;doi=10.3389/fphar.2022.938134&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b62-ijo-67-03-05783">
<span class="label">62.</span><cite>Yang L, Tang Y, Zhang Y, Wang Y, Jiang P, Liu F, Feng N. Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer. Sci Rep. 2024;14:9570. doi: 10.1038/s41598-024-57303-8.</cite> [<a href="https://doi.org/10.1038/s41598-024-57303-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11053037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38671021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Comprehensiveness%20cuproptosis%20related%20genes%20study%20for%20prognosis%20and%20medication%20sensitiveness%20across%20cancers,%20and%20validation%20in%20prostate%20cancer&amp;author=L%20Yang&amp;author=Y%20Tang&amp;author=Y%20Zhang&amp;author=Y%20Wang&amp;author=P%20Jiang&amp;volume=14&amp;publication_year=2024&amp;pages=9570&amp;pmid=38671021&amp;doi=10.1038/s41598-024-57303-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b63-ijo-67-03-05783">
<span class="label">63.</span><cite>Yang Q, Zeng S, Liu W. Roles of cuproptosis-related gene DLAT in various cancers: A bioinformatic analysis and preliminary verification on pro-survival autophagy. PeerJ. 2023;11:e15019. doi: 10.7717/peerj.15019.</cite> [<a href="https://doi.org/10.7717/peerj.15019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10026716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36949759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PeerJ&amp;title=Roles%20of%20cuproptosis-related%20gene%20DLAT%20in%20various%20cancers:%20A%20bioinformatic%20analysis%20and%20preliminary%20verification%20on%20pro-survival%20autophagy&amp;author=Q%20Yang&amp;author=S%20Zeng&amp;author=W%20Liu&amp;volume=11&amp;publication_year=2023&amp;pages=e15019&amp;pmid=36949759&amp;doi=10.7717/peerj.15019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b64-ijo-67-03-05783">
<span class="label">64.</span><cite>Li C, Xiao Y, Cao H, Chen Y, Li S, Yin F. Cuproptosis regulates microenvironment and affects prognosis in prostate cancer. BIOL Trace Elem Res. 2024;202:99–110. doi: 10.1007/s12011-023-03668-2.</cite> [<a href="https://doi.org/10.1007/s12011-023-03668-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37155084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BIOL%20Trace%20Elem%20Res&amp;title=Cuproptosis%20regulates%20microenvironment%20and%20affects%20prognosis%20in%20prostate%20cancer&amp;author=C%20Li&amp;author=Y%20Xiao&amp;author=H%20Cao&amp;author=Y%20Chen&amp;author=S%20Li&amp;volume=202&amp;publication_year=2024&amp;pages=99-110&amp;pmid=37155084&amp;doi=10.1007/s12011-023-03668-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b65-ijo-67-03-05783">
<span class="label">65.</span><cite>Xiao S, Lou W. Integrated analysis reveals a potential cuproptosis-related ceRNA axis SNHG17/miR-29a-3p/GCSH in prostate adenocarcinoma. Heliyon. 2023;9:e21506. doi: 10.1016/j.heliyon.2023.e21506.</cite> [<a href="https://doi.org/10.1016/j.heliyon.2023.e21506" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10651496/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38027603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heliyon&amp;title=Integrated%20analysis%20reveals%20a%20potential%20cuproptosis-related%20ceRNA%20axis%20SNHG17/miR-29a-3p/GCSH%20in%20prostate%20adenocarcinoma&amp;author=S%20Xiao&amp;author=W%20Lou&amp;volume=9&amp;publication_year=2023&amp;pages=e21506&amp;pmid=38027603&amp;doi=10.1016/j.heliyon.2023.e21506&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b66-ijo-67-03-05783">
<span class="label">66.</span><cite>Zhang D, Wang T, Zhou Y, Zhang X. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors. Medicine (Baltimore) 2023;102:e33468. doi: 10.1097/MD.0000000000033468.</cite> [<a href="https://doi.org/10.1097/MD.0000000000033468" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10082276/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37026918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicine%20(Baltimore)&amp;title=Comprehensive%20analyses%20of%20cuproptosis-related%20gene%20CDKN2A%20on%20prognosis%20and%20immunologic%20therapy%20in%20human%20tumors&amp;author=D%20Zhang&amp;author=T%20Wang&amp;author=Y%20Zhou&amp;author=X%20Zhang&amp;volume=102&amp;publication_year=2023&amp;pages=e33468&amp;pmid=37026918&amp;doi=10.1097/MD.0000000000033468&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b67-ijo-67-03-05783">
<span class="label">67.</span><cite>Lin SC, Tsai YC, Chen YL, Lin HK, Huang YC, Lin YS, Cheng YS, Chen HY, Li CJ, Lin TY, Lin SC. Un-methylation of NUDT21 represses docosahexaenoic acid biosynthesis contributing to enzalutamide resistance in prostate cancer. Drug Resist Update. 2024;77:101144. doi: 10.1016/j.drup.2024.101144.</cite> [<a href="https://doi.org/10.1016/j.drup.2024.101144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39208673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Resist%20Update&amp;title=Un-methylation%20of%20NUDT21%20represses%20docosahexaenoic%20acid%20biosynthesis%20contributing%20to%20enzalutamide%20resistance%20in%20prostate%20cancer&amp;author=SC%20Lin&amp;author=YC%20Tsai&amp;author=YL%20Chen&amp;author=HK%20Lin&amp;author=YC%20Huang&amp;volume=77&amp;publication_year=2024&amp;pages=101144&amp;pmid=39208673&amp;doi=10.1016/j.drup.2024.101144&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b68-ijo-67-03-05783">
<span class="label">68.</span><cite>Tang D, Kroemer G, Kang R. Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol. 2024;21:370–388. doi: 10.1038/s41571-024-00876-0.</cite> [<a href="https://doi.org/10.1038/s41571-024-00876-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38486054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&amp;title=Targeting%20cuproplasia%20and%20cuproptosis%20in%20cancer&amp;author=D%20Tang&amp;author=G%20Kroemer&amp;author=R%20Kang&amp;volume=21&amp;publication_year=2024&amp;pages=370-388&amp;pmid=38486054&amp;doi=10.1038/s41571-024-00876-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b69-ijo-67-03-05783">
<span class="label">69.</span><cite>Di Meo S, Reed TT, Venditti P, Victor VM. Role of ROS and RNS sources in physiological and pathological conditions. Oxid Med Cell Longev. 2016;2016:1245049. doi: 10.1155/2016/1245049.</cite> [<a href="https://doi.org/10.1155/2016/1245049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4960346/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27478531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oxid%20Med%20Cell%20Longev&amp;title=Role%20of%20ROS%20and%20RNS%20sources%20in%20physiological%20and%20pathological%20conditions&amp;author=S%20Di%20Meo&amp;author=TT%20Reed&amp;author=P%20Venditti&amp;author=VM%20Victor&amp;volume=2016&amp;publication_year=2016&amp;pages=1245049&amp;pmid=27478531&amp;doi=10.1155/2016/1245049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b70-ijo-67-03-05783">
<span class="label">70.</span><cite>Han C, Wang Z, Xu Y, Chen S, Han Y, Li L, Wang M, Jin X. Roles of reactive oxygen species in biological behaviors of prostate cancer. Biomed Res Int. 2020;2020:1269624. doi: 10.1155/2020/1269624.</cite> [<a href="https://doi.org/10.1155/2020/1269624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7538255/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33062666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Res%20Int&amp;title=Roles%20of%20reactive%20oxygen%20species%20in%20biological%20behaviors%20of%20prostate%20cancer&amp;author=C%20Han&amp;author=Z%20Wang&amp;author=Y%20Xu&amp;author=S%20Chen&amp;author=Y%20Han&amp;volume=2020&amp;publication_year=2020&amp;pages=1269624&amp;pmid=33062666&amp;doi=10.1155/2020/1269624&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b71-ijo-67-03-05783">
<span class="label">71.</span><cite>Liu Y, Chen A, Wu Y, Ni J, Wang R, Mao Y, Sun N, Mi Y. Identification of mitochondrial carrier homolog 2 as an important therapeutic target of castration-resistant prostate cancer. Cell Death Dis. 2025;16:70. doi: 10.1038/s41419-025-07406-5.</cite> [<a href="https://doi.org/10.1038/s41419-025-07406-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11799199/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39910035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Identification%20of%20mitochondrial%20carrier%20homolog%202%20as%20an%20important%20therapeutic%20target%20of%20castration-resistant%20prostate%20cancer&amp;author=Y%20Liu&amp;author=A%20Chen&amp;author=Y%20Wu&amp;author=J%20Ni&amp;author=R%20Wang&amp;volume=16&amp;publication_year=2025&amp;pages=70&amp;pmid=39910035&amp;doi=10.1038/s41419-025-07406-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b72-ijo-67-03-05783">
<span class="label">72.</span><cite>Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Lett. 2009;282:125–136. doi: 10.1016/j.canlet.2008.12.011.</cite> [<a href="https://doi.org/10.1016/j.canlet.2008.12.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2789743/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19185987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett&amp;title=Oxidative%20stress%20in%20prostate%20cancer&amp;author=L%20Khandrika&amp;author=B%20Kumar&amp;author=S%20Koul&amp;author=P%20Maroni&amp;author=HK%20Koul&amp;volume=282&amp;publication_year=2009&amp;pages=125-136&amp;pmid=19185987&amp;doi=10.1016/j.canlet.2008.12.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b73-ijo-67-03-05783">
<span class="label">73.</span><cite>Baohai X, Shi F, Yongqi F. Inhibition of ubiquitin specific protease 17 restrains prostate cancer proliferation by regulation of epithelial-to-mesenchymal transition (EMT) via ROS production. Biomed Pharmacother. 2019;118:108946. doi: 10.1016/j.biopha.2019.108946.</cite> [<a href="https://doi.org/10.1016/j.biopha.2019.108946" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31377470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Pharmacother&amp;title=Inhibition%20of%20ubiquitin%20specific%20protease%2017%20restrains%20prostate%20cancer%20proliferation%20by%20regulation%20of%20epithelial-to-mesenchymal%20transition%20(EMT)%20via%20ROS%20production&amp;author=X%20Baohai&amp;author=F%20Shi&amp;author=F%20Yongqi&amp;volume=118&amp;publication_year=2019&amp;pages=108946&amp;pmid=31377470&amp;doi=10.1016/j.biopha.2019.108946&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b74-ijo-67-03-05783">
<span class="label">74.</span><cite>Lee W, Kim KY, Yu SN, Kim SH, Chun SS, Ji JH, Yu HS, Ahn SC. Pipernonaline from Piper longum Linn. induces ROS-mediated apoptosis in human prostate cancer PC-3 cells. Biochem Biophys Res Commun. 2013;430:406–412. doi: 10.1016/j.bbrc.2012.11.030.</cite> [<a href="https://doi.org/10.1016/j.bbrc.2012.11.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23159637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun&amp;title=Pipernonaline%20from%20Piper%20longum%20Linn.%20induces%20ROS-mediated%20apoptosis%20in%20human%20prostate%20cancer%20PC-3%20cells&amp;author=W%20Lee&amp;author=KY%20Kim&amp;author=SN%20Yu&amp;author=SH%20Kim&amp;author=SS%20Chun&amp;volume=430&amp;publication_year=2013&amp;pages=406-412&amp;pmid=23159637&amp;doi=10.1016/j.bbrc.2012.11.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b75-ijo-67-03-05783">
<span class="label">75.</span><cite>Kim SH, Kim KY, Yu SN, Park SG, Yu HS, Seo YK, Ahn SC. Monensin induces PC-3 prostate cancer cell apoptosis via ROS production and Ca2+ homeostasis disruption. Anticancer Res. 2016;36:5835–5843. doi: 10.21873/anticanres.11168.</cite> [<a href="https://doi.org/10.21873/anticanres.11168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27793906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer%20Res&amp;title=Monensin%20induces%20PC-3%20prostate%20cancer%20cell%20apoptosis%20via%20ROS%20production%20and%20Ca2+%20homeostasis%20disruption&amp;author=SH%20Kim&amp;author=KY%20Kim&amp;author=SN%20Yu&amp;author=SG%20Park&amp;author=HS%20Yu&amp;volume=36&amp;publication_year=2016&amp;pages=5835-5843&amp;pmid=27793906&amp;doi=10.21873/anticanres.11168&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b76-ijo-67-03-05783">
<span class="label">76.</span><cite>Farhan M, El Oirdi M, Aatif M, Nahvi I, Muteeb G, Alam MW. Soy isoflavones induce cell death by copper-mediated mechanism: Understanding its anticancer properties. Molecules. 2023;28:2925. doi: 10.3390/molecules28072925.</cite> [<a href="https://doi.org/10.3390/molecules28072925" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10095714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37049690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Soy%20isoflavones%20induce%20cell%20death%20by%20copper-mediated%20mechanism:%20Understanding%20its%20anticancer%20properties&amp;author=M%20Farhan&amp;author=M%20El%20Oirdi&amp;author=M%20Aatif&amp;author=I%20Nahvi&amp;author=G%20Muteeb&amp;volume=28&amp;publication_year=2023&amp;pages=2925&amp;pmid=37049690&amp;doi=10.3390/molecules28072925&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b77-ijo-67-03-05783">
<span class="label">77.</span><cite>Alhasawi M, Aatif M, Muteeb G, Alam MW, Oirdi ME, Farhan M. Curcumin and its derivatives induce apoptosis in human cancer cells by mobilizing and redox cycling genomic copper ions. Molecules. 2022;27:7410. doi: 10.3390/molecules27217410.</cite> [<a href="https://doi.org/10.3390/molecules27217410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9659251/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36364236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Curcumin%20and%20its%20derivatives%20induce%20apoptosis%20in%20human%20cancer%20cells%20by%20mobilizing%20and%20redox%20cycling%20genomic%20copper%20ions&amp;author=M%20Alhasawi&amp;author=M%20Aatif&amp;author=G%20Muteeb&amp;author=MW%20Alam&amp;author=ME%20Oirdi&amp;volume=27&amp;publication_year=2022&amp;pages=7410&amp;pmid=36364236&amp;doi=10.3390/molecules27217410&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b78-ijo-67-03-05783">
<span class="label">78.</span><cite>Farhan M, Rizvi A, Ali F, Ahmad A, Aatif M, Malik A, Alam MW, Muteeb G, Ahmad S, Noor A, Siddiqui FA. Pomegranate juice anthocyanidins induce cell death in human cancer cells by mobilizing intracellular copper ions and producing reactive oxygen species. Front Oncol. 2022;12:998346. doi: 10.3389/fonc.2022.998346.</cite> [<a href="https://doi.org/10.3389/fonc.2022.998346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9487716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36147917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Pomegranate%20juice%20anthocyanidins%20induce%20cell%20death%20in%20human%20cancer%20cells%20by%20mobilizing%20intracellular%20copper%20ions%20and%20producing%20reactive%20oxygen%20species&amp;author=M%20Farhan&amp;author=A%20Rizvi&amp;author=F%20Ali&amp;author=A%20Ahmad&amp;author=M%20Aatif&amp;volume=12&amp;publication_year=2022&amp;pages=998346&amp;pmid=36147917&amp;doi=10.3389/fonc.2022.998346&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b79-ijo-67-03-05783">
<span class="label">79.</span><cite>Denoyer D, Pearson HB, Clatworthy SA, Smith ZM, Francis PS, Llanos RM, Volitakis I, Phillips WA, Meggyesy PM, Masaldan S, Cater MA. Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution. Oncotarget. 2016;7:37064–37080. doi: 10.18632/oncotarget.9245.</cite> [<a href="https://doi.org/10.18632/oncotarget.9245" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5095059/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27175597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Copper%20as%20a%20target%20for%20prostate%20cancer%20therapeutics:%20copper-ionophore%20pharmacology%20and%20altering%20systemic%20copper%20distribution&amp;author=D%20Denoyer&amp;author=HB%20Pearson&amp;author=SA%20Clatworthy&amp;author=ZM%20Smith&amp;author=PS%20Francis&amp;volume=7&amp;publication_year=2016&amp;pages=37064-37080&amp;pmid=27175597&amp;doi=10.18632/oncotarget.9245&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b80-ijo-67-03-05783">
<span class="label">80.</span><cite>Song L, Nguyen V, Xie J, Jia S, Chang CJ, Uchio E, Zi X. ATPase copper transporting beta (ATP7B) is a novel target for improving the therapeutic efficacy of docetaxel by disulfiram/copper in human prostate cancer. Mol Cancer Ther. 2024;23:854–863. doi: 10.1158/1535-7163.MCT-23-0876.</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-23-0876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11150099/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38417139/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Ther&amp;title=ATPase%20copper%20transporting%20beta%20(ATP7B)%20is%20a%20novel%20target%20for%20improving%20the%20therapeutic%20efficacy%20of%20docetaxel%20by%20disulfiram/copper%20in%20human%20prostate%20cancer&amp;author=L%20Song&amp;author=V%20Nguyen&amp;author=J%20Xie&amp;author=S%20Jia&amp;author=CJ%20Chang&amp;volume=23&amp;publication_year=2024&amp;pages=854-863&amp;pmid=38417139&amp;doi=10.1158/1535-7163.MCT-23-0876&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b81-ijo-67-03-05783">
<span class="label">81.</span><cite>Vo T, Peng TY, Nguyen TH, Bui TNH, Wang CS, Lee WJ, Chen YL, Wu YC, Lee IT. The crosstalk between copper-induced oxidative stress and cuproptosis: A novel potential anticancer paradigm. Cell Commun Signal. 2024;22:353. doi: 10.1186/s12964-024-01726-3.</cite> [<a href="https://doi.org/10.1186/s12964-024-01726-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11225285/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38970072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Commun%20Signal&amp;title=The%20crosstalk%20between%20copper-induced%20oxidative%20stress%20and%20cuproptosis:%20A%20novel%20potential%20anticancer%20paradigm&amp;author=T%20Vo&amp;author=TY%20Peng&amp;author=TH%20Nguyen&amp;author=TNH%20Bui&amp;author=CS%20Wang&amp;volume=22&amp;publication_year=2024&amp;pages=353&amp;pmid=38970072&amp;doi=10.1186/s12964-024-01726-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b82-ijo-67-03-05783">
<span class="label">82.</span><cite>Onuma T, Mizutani T, Fujita Y, Yamada S, Yoshida Y. Copper content in ascitic fluid is associated with angiogenesis and progression in ovarian cancer. J Trace Elem Med Biol. 2021;68:126865. doi: 10.1016/j.jtemb.2021.126865.</cite> [<a href="https://doi.org/10.1016/j.jtemb.2021.126865" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34601284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Trace%20Elem%20Med%20Biol&amp;title=Copper%20content%20in%20ascitic%20fluid%20is%20associated%20with%20angiogenesis%20and%20progression%20in%20ovarian%20cancer&amp;author=T%20Onuma&amp;author=T%20Mizutani&amp;author=Y%20Fujita&amp;author=S%20Yamada&amp;author=Y%20Yoshida&amp;volume=68&amp;publication_year=2021&amp;pages=126865&amp;pmid=34601284&amp;doi=10.1016/j.jtemb.2021.126865&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b83-ijo-67-03-05783">
<span class="label">83.</span><cite>Oliveri V. Selective targeting of cancer cells by copper ionophores: An overview. Front Mol Biosci. 2022;9:841814. doi: 10.3389/fmolb.2022.841814.</cite> [<a href="https://doi.org/10.3389/fmolb.2022.841814" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8931543/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35309510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Mol%20Biosci&amp;title=Selective%20targeting%20of%20cancer%20cells%20by%20copper%20ionophores:%20An%20overview&amp;author=V%20Oliveri&amp;volume=9&amp;publication_year=2022&amp;pages=841814&amp;pmid=35309510&amp;doi=10.3389/fmolb.2022.841814&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b84-ijo-67-03-05783">
<span class="label">84.</span><cite>Melegh Z, Oltean S. Targeting angiogenesis in prostate cancer. Int J Mol Sci. 2019;20:2676. doi: 10.3390/ijms20112676.</cite> [<a href="https://doi.org/10.3390/ijms20112676" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6600172/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31151317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Targeting%20angiogenesis%20in%20prostate%20cancer&amp;author=Z%20Melegh&amp;author=S%20Oltean&amp;volume=20&amp;publication_year=2019&amp;pages=2676&amp;pmid=31151317&amp;doi=10.3390/ijms20112676&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b85-ijo-67-03-05783">
<span class="label">85.</span><cite>Ioannidou E, Moschetta M, Shah S, Parker JS, Ozturk MA, Pappas-Gogos G, Sheriff M, Rassy E, Boussios S. Angiogenesis and anti-angiogenic treatment in prostate cancer: mechanisms of action and molecular targets. Int J Mol Sci. 2021;22:9926. doi: 10.3390/ijms22189926.</cite> [<a href="https://doi.org/10.3390/ijms22189926" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8472415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34576107/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Angiogenesis%20and%20anti-angiogenic%20treatment%20in%20prostate%20cancer:%20mechanisms%20of%20action%20and%20molecular%20targets&amp;author=E%20Ioannidou&amp;author=M%20Moschetta&amp;author=S%20Shah&amp;author=JS%20Parker&amp;author=MA%20Ozturk&amp;volume=22&amp;publication_year=2021&amp;pages=9926&amp;pmid=34576107&amp;doi=10.3390/ijms22189926&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b86-ijo-67-03-05783">
<span class="label">86.</span><cite>Fang J, Ding M, Yang L, Liu LZ, Jiang BH. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal. 2007;19:2487–2497. doi: 10.1016/j.cellsig.2007.07.025.</cite> [<a href="https://doi.org/10.1016/j.cellsig.2007.07.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2094004/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17826033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Signal&amp;title=PI3K/PTEN/AKT%20signaling%20regulates%20prostate%20tumor%20angiogenesis&amp;author=J%20Fang&amp;author=M%20Ding&amp;author=L%20Yang&amp;author=LZ%20Liu&amp;author=BH%20Jiang&amp;volume=19&amp;publication_year=2007&amp;pages=2487-2497&amp;pmid=17826033&amp;doi=10.1016/j.cellsig.2007.07.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b87-ijo-67-03-05783">
<span class="label">87.</span><cite>Marin-Aguilera M, Pereira MV, Jimenez N, Reig Ò, Cuartero A, Victoria I, Aversa C, Ferrer-Mileo L, Prat A, Mellado B. Glutamine and cholesterol plasma levels and clinical outcomes of patients with metastatic castration-resistant prostate cancer treated with taxanes. Cancers (Basel) 2021;13:4960. doi: 10.3390/cancers13194960.</cite> [<a href="https://doi.org/10.3390/cancers13194960" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8507765/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34638444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Glutamine%20and%20cholesterol%20plasma%20levels%20and%20clinical%20outcomes%20of%20patients%20with%20metastatic%20castration-resistant%20prostate%20cancer%20treated%20with%20taxanes&amp;author=M%20Marin-Aguilera&amp;author=MV%20Pereira&amp;author=N%20Jimenez&amp;author=%C3%92%20Reig&amp;author=A%20Cuartero&amp;volume=13&amp;publication_year=2021&amp;pages=4960&amp;pmid=34638444&amp;doi=10.3390/cancers13194960&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b88-ijo-67-03-05783">
<span class="label">88.</span><cite>Yue S, Li J, Lee SY, Lee HJ, Shao T, Song B, Cheng L, Masterson TA, Liu X, Ratliff TL, Cheng JX. Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 2014;19:393–406. doi: 10.1016/j.cmet.2014.01.019.</cite> [<a href="https://doi.org/10.1016/j.cmet.2014.01.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3969850/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24606897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metab&amp;title=Cholesteryl%20ester%20accumulation%20induced%20by%20PTEN%20loss%20and%20PI3K/AKT%20activation%20underlies%20human%20prostate%20cancer%20aggressiveness&amp;author=S%20Yue&amp;author=J%20Li&amp;author=SY%20Lee&amp;author=HJ%20Lee&amp;author=T%20Shao&amp;volume=19&amp;publication_year=2014&amp;pages=393-406&amp;pmid=24606897&amp;doi=10.1016/j.cmet.2014.01.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b89-ijo-67-03-05783">
<span class="label">89.</span><cite>Lee HJ, Li J, Vickman RE, Li J, Liu R, Durkes AC, Elzey BD, Yue S, Liu X, Ratliff TL, Cheng JX. Cholesterol esterification inhibition suppresses prostate cancer metastasis by impairing the wnt/β-catenin pathway. Mol Cancer Res. 2018;16:974–985. doi: 10.1158/1541-7786.MCR-17-0665.</cite> [<a href="https://doi.org/10.1158/1541-7786.MCR-17-0665" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5984676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29545473/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Res&amp;title=Cholesterol%20esterification%20inhibition%20suppresses%20prostate%20cancer%20metastasis%20by%20impairing%20the%20wnt/%CE%B2-catenin%20pathway&amp;author=HJ%20Lee&amp;author=J%20Li&amp;author=RE%20Vickman&amp;author=J%20Li&amp;author=R%20Liu&amp;volume=16&amp;publication_year=2018&amp;pages=974-985&amp;pmid=29545473&amp;doi=10.1158/1541-7786.MCR-17-0665&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b90-ijo-67-03-05783">
<span class="label">90.</span><cite>Liu YT, Chen L, Li SJ, Wang WY, Wang YY, Yang QC, Song A, Zhang MJ, Mo WT, Li H, et al.  Dysregulated Wnt/β-catenin signaling confers resistance to cuproptosis in cancer cells. Cell Death Differ. 2024;31:1452–1466. doi: 10.1038/s41418-024-01341-2.</cite> [<a href="https://doi.org/10.1038/s41418-024-01341-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11520902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38987382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Differ&amp;title=Dysregulated%20Wnt/%CE%B2-catenin%20signaling%20confers%20resistance%20to%20cuproptosis%20in%20cancer%20cells&amp;author=YT%20Liu&amp;author=L%20Chen&amp;author=SJ%20Li&amp;author=WY%20Wang&amp;author=YY%20Wang&amp;volume=31&amp;publication_year=2024&amp;pages=1452-1466&amp;pmid=38987382&amp;doi=10.1038/s41418-024-01341-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b91-ijo-67-03-05783">
<span class="label">91.</span><cite>Song X, Wang W, Li Z, Zhang D. Association between serum copper and serum lipids in adults. Ann Nutr Metab. 2018;73:282–289. doi: 10.1159/000494032.</cite> [<a href="https://doi.org/10.1159/000494032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30368500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Nutr%20Metab&amp;title=Association%20between%20serum%20copper%20and%20serum%20lipids%20in%20adults&amp;author=X%20Song&amp;author=W%20Wang&amp;author=Z%20Li&amp;author=D%20Zhang&amp;volume=73&amp;publication_year=2018&amp;pages=282-289&amp;pmid=30368500&amp;doi=10.1159/000494032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b92-ijo-67-03-05783">
<span class="label">92.</span><cite>Pan YX, Zhuo MQ, Li DD, Xu YH, Wu K, Luo Z. SREBP-1 and LXRα pathways mediated Cu-induced hepatic lipid metabolism in zebrafish Danio rerio. Chemosphere. 2019;215:370–379. doi: 10.1016/j.chemosphere.2018.10.058.</cite> [<a href="https://doi.org/10.1016/j.chemosphere.2018.10.058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30336314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chemosphere&amp;title=SREBP-1%20and%20LXR%CE%B1%20pathways%20mediated%20Cu-induced%20hepatic%20lipid%20metabolism%20in%20zebrafish%20Danio%20rerio&amp;author=YX%20Pan&amp;author=MQ%20Zhuo&amp;author=DD%20Li&amp;author=YH%20Xu&amp;author=K%20Wu&amp;volume=215&amp;publication_year=2019&amp;pages=370-379&amp;pmid=30336314&amp;doi=10.1016/j.chemosphere.2018.10.058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b93-ijo-67-03-05783">
<span class="label">93.</span><cite>Xu YC, Xu YH, Zhao T, Wu LX, Yang SB, Luo Z. Waterborne Cu exposure increased lipid deposition and lipogenesis by affecting Wnt/β-catenin pathway and the beta-catenin acetylation levels of grass carp Ctenopharyngodon idella. Environ Pollut. 2020;263(Pt B):114420. doi: 10.1016/j.envpol.2020.114420.</cite> [<a href="https://doi.org/10.1016/j.envpol.2020.114420" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32244122/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ%20Pollut&amp;title=Waterborne%20Cu%20exposure%20increased%20lipid%20deposition%20and%20lipogenesis%20by%20affecting%20Wnt/%CE%B2-catenin%20pathway%20and%20the%20beta-catenin%20acetylation%20levels%20of%20grass%20carp%20Ctenopharyngodon%20idella&amp;author=YC%20Xu&amp;author=YH%20Xu&amp;author=T%20Zhao&amp;author=LX%20Wu&amp;author=SB%20Yang&amp;volume=263&amp;issue=Pt%20B&amp;publication_year=2020&amp;pages=114420&amp;pmid=32244122&amp;doi=10.1016/j.envpol.2020.114420&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b94-ijo-67-03-05783">
<span class="label">94.</span><cite>Yang L, Yang P, Lip GYH, Ren J. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. Trends Pharmacol Sci. 2023;44:573–585. doi: 10.1016/j.tips.2023.07.004.</cite> [<a href="https://doi.org/10.1016/j.tips.2023.07.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37500296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Pharmacol%20Sci&amp;title=Copper%20homeostasis%20and%20cuproptosis%20in%20cardiovascular%20disease%20therapeutics&amp;author=L%20Yang&amp;author=P%20Yang&amp;author=GYH%20Lip&amp;author=J%20Ren&amp;volume=44&amp;publication_year=2023&amp;pages=573-585&amp;pmid=37500296&amp;doi=10.1016/j.tips.2023.07.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b95-ijo-67-03-05783">
<span class="label">95.</span><cite>Wen H, Qu C, Wang Z, Gao H, Liu W, Wang H, Sun H, Gu J, Yang Z, Wang X. Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer. FASEB J. 2023;37:e23145. doi: 10.1096/fj.202300980R.</cite> [<a href="https://doi.org/10.1096/fj.202300980R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37584654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J&amp;title=Cuproptosis%20enhances%20docetaxel%20chemosensitivity%20by%20inhibiting%20autophagy%20via%20the%20DLAT/mTOR%20pathway%20in%20prostate%20cancer&amp;author=H%20Wen&amp;author=C%20Qu&amp;author=Z%20Wang&amp;author=H%20Gao&amp;author=W%20Liu&amp;volume=37&amp;publication_year=2023&amp;pages=e23145&amp;pmid=37584654&amp;doi=10.1096/fj.202300980R&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b96-ijo-67-03-05783">
<span class="label">96.</span><cite>Zhang H, Chen D, Ringler J, Chen W, Cui QC, Ethier SP, Dou QP, Wu G. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo. Cancer Res. 2010;70:3996–4004. doi: 10.1158/0008-5472.CAN-09-3752.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-09-3752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3827685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20424113/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Disulfiram%20treatment%20facilitates%20phosphoinositide%203-kinase%20inhibition%20in%20human%20breast%20cancer%20cells%20in%20vitro%20and%20in%20vivo&amp;author=H%20Zhang&amp;author=D%20Chen&amp;author=J%20Ringler&amp;author=W%20Chen&amp;author=QC%20Cui&amp;volume=70&amp;publication_year=2010&amp;pages=3996-4004&amp;pmid=20424113&amp;doi=10.1158/0008-5472.CAN-09-3752&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b97-ijo-67-03-05783">
<span class="label">97.</span><cite>Bergez-Hernandez F, Irigoyen-Arredondo M, Martinez-Camberos A. A systematic review of mechanisms of PTEN gene down-regulation mediated by miRNA in prostate cancer. Heliyon. 2024;10:e34950. doi: 10.1016/j.heliyon.2024.e34950.</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e34950" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11320309/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39144981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heliyon&amp;title=A%20systematic%20review%20of%20mechanisms%20of%20PTEN%20gene%20down-regulation%20mediated%20by%20miRNA%20in%20prostate%20cancer&amp;author=F%20Bergez-Hernandez&amp;author=M%20Irigoyen-Arredondo&amp;author=A%20Martinez-Camberos&amp;volume=10&amp;publication_year=2024&amp;pages=e34950&amp;pmid=39144981&amp;doi=10.1016/j.heliyon.2024.e34950&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b98-ijo-67-03-05783">
<span class="label">98.</span><cite>Marques RB, Aghai A, de Ridder CMA, Stuurman D, Hoeben S, Boer A, Ellston RP, Barry ST, Davies BR, Trapman J, van Weerden WM. High efficacy of combination therapy using PI3K/AKT inhibitors with androgen deprivation in prostate cancer preclinical models. Eur Urol. 2015;67:1177–1185. doi: 10.1016/j.eururo.2014.08.053.</cite> [<a href="https://doi.org/10.1016/j.eururo.2014.08.053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25220373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Urol&amp;title=High%20efficacy%20of%20combination%20therapy%20using%20PI3K/AKT%20inhibitors%20with%20androgen%20deprivation%20in%20prostate%20cancer%20preclinical%20models&amp;author=RB%20Marques&amp;author=A%20Aghai&amp;author=CMA%20de%20Ridder&amp;author=D%20Stuurman&amp;author=S%20Hoeben&amp;volume=67&amp;publication_year=2015&amp;pages=1177-1185&amp;pmid=25220373&amp;doi=10.1016/j.eururo.2014.08.053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b99-ijo-67-03-05783">
<span class="label">99.</span><cite>Lin J, Haffner MC, Zhang Y, Lee BH, Brennen WN, Britton J, Kachhap SK, Shim JS, Liu JO, Nelson WG, et al.  Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. Prostate. 2011;71:333–343. doi: 10.1002/pros.21247.</cite> [<a href="https://doi.org/10.1002/pros.21247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3043358/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20809552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Disulfiram%20is%20a%20DNA%20demethylating%20agent%20and%20inhibits%20prostate%20cancer%20cell%20growth&amp;author=J%20Lin&amp;author=MC%20Haffner&amp;author=Y%20Zhang&amp;author=BH%20Lee&amp;author=WN%20Brennen&amp;volume=71&amp;publication_year=2011&amp;pages=333-343&amp;pmid=20809552&amp;doi=10.1002/pros.21247&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b100-ijo-67-03-05783">
<span class="label">100.</span><cite>Iljin K, Ketola K, Vainio P, Halonen P, Kohonen P, Fey V, Grafström RC, Perälä M, Kallioniemi O. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res. 2009;15:6070–6078. doi: 10.1158/1078-0432.CCR-09-1035.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-09-1035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19789329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=High-throughput%20cell-based%20screening%20of%204910%20known%20drugs%20and%20drug-like%20small%20molecules%20identifies%20disulfiram%20as%20an%20inhibitor%20of%20prostate%20cancer%20cell%20growth&amp;author=K%20Iljin&amp;author=K%20Ketola&amp;author=P%20Vainio&amp;author=P%20Halonen&amp;author=P%20Kohonen&amp;volume=15&amp;publication_year=2009&amp;pages=6070-6078&amp;pmid=19789329&amp;doi=10.1158/1078-0432.CCR-09-1035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b101-ijo-67-03-05783">
<span class="label">101.</span><cite>Tesson M, Rae C, Nixon C, Babich JW, Mairs RJ. Preliminary evaluation of prostate-targeted radiotherapy using 131I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs. J Pharm Pharmacol. 2016;68:912–921. doi: 10.1111/jphp.12558.</cite> [<a href="https://doi.org/10.1111/jphp.12558" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5298040/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27139157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharm%20Pharmacol&amp;title=Preliminary%20evaluation%20of%20prostate-targeted%20radiotherapy%20using%20131I-MIP-1095%20in%20combination%20with%20radiosensitising%20chemotherapeutic%20drugs&amp;author=M%20Tesson&amp;author=C%20Rae&amp;author=C%20Nixon&amp;author=JW%20Babich&amp;author=RJ%20Mairs&amp;volume=68&amp;publication_year=2016&amp;pages=912-921&amp;pmid=27139157&amp;doi=10.1111/jphp.12558&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b102-ijo-67-03-05783">
<span class="label">102.</span><cite>Castoldi F, Hyvonen MT, Durand S, Aprahamian F, Sauvat A, Malik SA, Baracco EE, Vacchelli E, Opolon P, Signolle N, et al.  Chemical activation of SAT1 corrects diet-induced metabolic syndrome. Cell Death Differ. 2020;27:2904–2920. doi: 10.1038/s41418-020-0550-z.</cite> [<a href="https://doi.org/10.1038/s41418-020-0550-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7494776/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32376874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Differ&amp;title=Chemical%20activation%20of%20SAT1%20corrects%20diet-induced%20metabolic%20syndrome&amp;author=F%20Castoldi&amp;author=MT%20Hyvonen&amp;author=S%20Durand&amp;author=F%20Aprahamian&amp;author=A%20Sauvat&amp;volume=27&amp;publication_year=2020&amp;pages=2904-2920&amp;pmid=32376874&amp;doi=10.1038/s41418-020-0550-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b103-ijo-67-03-05783">
<span class="label">103.</span><cite>Vetrik M, Mattova J, Mackova H, Kucka J, Pouckova P, Kukackova O, Brus J, Eigner-Henke S, Sedlacek O, Sefc L, et al.  Biopolymer strategy for the treatment of Wilson's disease. J Control Release. 2018;273:131–138. doi: 10.1016/j.jconrel.2018.01.026.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2018.01.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29407674/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=Biopolymer%20strategy%20for%20the%20treatment%20of%20Wilson's%20disease&amp;author=M%20Vetrik&amp;author=J%20Mattova&amp;author=H%20Mackova&amp;author=J%20Kucka&amp;author=P%20Pouckova&amp;volume=273&amp;publication_year=2018&amp;pages=131-138&amp;pmid=29407674&amp;doi=10.1016/j.jconrel.2018.01.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b104-ijo-67-03-05783">
<span class="label">104.</span><cite>Mao L, Huang CH, Shao J, Qin L, Xu D, Shao B, Zhu BZ. An unexpected antioxidant and redox activity for the classic copper-chelating drug penicillamine. Free Radic Biol Med. 2020;147:150–158. doi: 10.1016/j.freeradbiomed.2019.12.013.</cite> [<a href="https://doi.org/10.1016/j.freeradbiomed.2019.12.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31857235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Free%20Radic%20Biol%20Med&amp;title=An%20unexpected%20antioxidant%20and%20redox%20activity%20for%20the%20classic%20copper-chelating%20drug%20penicillamine&amp;author=L%20Mao&amp;author=CH%20Huang&amp;author=J%20Shao&amp;author=L%20Qin&amp;author=D%20Xu&amp;volume=147&amp;publication_year=2020&amp;pages=150-158&amp;pmid=31857235&amp;doi=10.1016/j.freeradbiomed.2019.12.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b105-ijo-67-03-05783">
<span class="label">105.</span><cite>Kenney GE, Rosenzweig AC. Chemistry and biology of the copper chelator methanobactin. ACS Chem Biol. 2012;7:260–268. doi: 10.1021/cb2003913.</cite> [<a href="https://doi.org/10.1021/cb2003913" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3288317/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22126187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Chem%20Biol&amp;title=Chemistry%20and%20biology%20of%20the%20copper%20chelator%20methanobactin&amp;author=GE%20Kenney&amp;author=AC%20Rosenzweig&amp;volume=7&amp;publication_year=2012&amp;pages=260-268&amp;pmid=22126187&amp;doi=10.1021/cb2003913&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b106-ijo-67-03-05783">
<span class="label">106.</span><cite>Lenartowicz M, Moos T, Ogorek M, Jensen TG, Moller LB. Metal-dependent regulation of ATP7A and ATP7B in fibroblast cultures. Front Mol Neurosci. 2016;9:68. doi: 10.3389/fnmol.2016.00068.</cite> [<a href="https://doi.org/10.3389/fnmol.2016.00068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4988979/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27587995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Mol%20Neurosci&amp;title=Metal-dependent%20regulation%20of%20ATP7A%20and%20ATP7B%20in%20fibroblast%20cultures&amp;author=M%20Lenartowicz&amp;author=T%20Moos&amp;author=M%20Ogorek&amp;author=TG%20Jensen&amp;author=LB%20Moller&amp;volume=9&amp;publication_year=2016&amp;pages=68&amp;pmid=27587995&amp;doi=10.3389/fnmol.2016.00068&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b107-ijo-67-03-05783">
<span class="label">107.</span><cite>Lee K, Briehl MM, Mazar AP, Batinic-Haberle I, Reboucas JS, Glinsmann-Gibson B, Rimsza LM, Tome ME. The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies. Free Radic Biol Med. 2013;60:157–167. doi: 10.1016/j.freeradbiomed.2013.02.003.</cite> [<a href="https://doi.org/10.1016/j.freeradbiomed.2013.02.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3654089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23416365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Free%20Radic%20Biol%20Med&amp;title=The%20copper%20chelator%20ATN-224%20induces%20peroxynitrite-dependent%20cell%20death%20in%20hematological%20malignancies&amp;author=K%20Lee&amp;author=MM%20Briehl&amp;author=AP%20Mazar&amp;author=I%20Batinic-Haberle&amp;author=JS%20Reboucas&amp;volume=60&amp;publication_year=2013&amp;pages=157-167&amp;pmid=23416365&amp;doi=10.1016/j.freeradbiomed.2013.02.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b108-ijo-67-03-05783">
<span class="label">108.</span><cite>Bakthavatsalam S, Sleeper ML, Dharani A, George DJ, Zhang T, Franz KJ. Leveraging γ-Glutamyl transferase to direct cytotoxicity of copper dithiocarbamates against prostate cancer cells. Angew Chem Int Ed Engl. 2018;57:12780–12784. doi: 10.1002/anie.201807582.</cite> [<a href="https://doi.org/10.1002/anie.201807582" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6372289/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30025197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew%20Chem%20Int%20Ed%20Engl&amp;title=Leveraging%20%CE%B3-Glutamyl%20transferase%20to%20direct%20cytotoxicity%20of%20copper%20dithiocarbamates%20against%20prostate%20cancer%20cells&amp;author=S%20Bakthavatsalam&amp;author=ML%20Sleeper&amp;author=A%20Dharani&amp;author=DJ%20George&amp;author=T%20Zhang&amp;volume=57&amp;publication_year=2018&amp;pages=12780-12784&amp;pmid=30025197&amp;doi=10.1002/anie.201807582&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b109-ijo-67-03-05783">
<span class="label">109.</span><cite>Wei C, Fu Q. Cell death mediated by nanotechnology via the cuproptosis pathway: A novel horizon for cancer therapy. VIEW-CHINA. 2023;4:20230001. doi: 10.1002/VIW.20230001.</cite> [<a href="https://doi.org/10.1002/VIW.20230001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=VIEW-CHINA&amp;title=Cell%20death%20mediated%20by%20nanotechnology%20via%20the%20cuproptosis%20pathway:%20A%20novel%20horizon%20for%20cancer%20therapy&amp;author=C%20Wei&amp;author=Q%20Fu&amp;volume=4&amp;publication_year=2023&amp;pages=20230001&amp;doi=10.1002/VIW.20230001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b110-ijo-67-03-05783">
<span class="label">110.</span><cite>Xie W, Zhang Y, Xu Q, Zhong G, Lin J, He H, Du Q, Tan H, Chen M, Wu Z, et al.  A Unique approach: biomimetic graphdiyne-based nanoplatform to treat prostate cancer by combining cuproptosis and enhanced chemodynamic therapy. Int J Nanomedicine. 2024;19:3957–3972. doi: 10.2147/IJN.S455355.</cite> [<a href="https://doi.org/10.2147/IJN.S455355" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11073530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38711614/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Nanomedicine&amp;title=A%20Unique%20approach:%20biomimetic%20graphdiyne-based%20nanoplatform%20to%20treat%20prostate%20cancer%20by%20combining%20cuproptosis%20and%20enhanced%20chemodynamic%20therapy&amp;author=W%20Xie&amp;author=Y%20Zhang&amp;author=Q%20Xu&amp;author=G%20Zhong&amp;author=J%20Lin&amp;volume=19&amp;publication_year=2024&amp;pages=3957-3972&amp;pmid=38711614&amp;doi=10.2147/IJN.S455355&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b111-ijo-67-03-05783">
<span class="label">111.</span><cite>Wang Y, Yang QW, Yang Q, Zhou T, Shi MF, Sun CX, Gao XX, Cheng YQ, Cui XG, Sun YH. Cuprous oxide nanoparticles inhibit prostate cancer by attenuating the stemness of cancer cells via inhibition of the Wnt signaling pathway. Int J Nanomedicine. 2017;12:2569–2579. doi: 10.2147/IJN.S130537.</cite> [<a href="https://doi.org/10.2147/IJN.S130537" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5383080/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28408824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Nanomedicine&amp;title=Cuprous%20oxide%20nanoparticles%20inhibit%20prostate%20cancer%20by%20attenuating%20the%20stemness%20of%20cancer%20cells%20via%20inhibition%20of%20the%20Wnt%20signaling%20pathway&amp;author=Y%20Wang&amp;author=QW%20Yang&amp;author=Q%20Yang&amp;author=T%20Zhou&amp;author=MF%20Shi&amp;volume=12&amp;publication_year=2017&amp;pages=2569-2579&amp;pmid=28408824&amp;doi=10.2147/IJN.S130537&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b112-ijo-67-03-05783">
<span class="label">112.</span><cite>Chen W, Yang W, Chen P, Huang Y, Li F. Disulfiram copper nanoparticles prepared with a stabilized metal ion ligand complex method for treating drug-resistant prostate cancers. ACS Appl Mater Interfaces. 2018;10:41118–41128. doi: 10.1021/acsami.8b14940.</cite> [<a href="https://doi.org/10.1021/acsami.8b14940" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30444340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl%20Mater%20Interfaces&amp;title=Disulfiram%20copper%20nanoparticles%20prepared%20with%20a%20stabilized%20metal%20ion%20ligand%20complex%20method%20for%20treating%20drug-resistant%20prostate%20cancers&amp;author=W%20Chen&amp;author=W%20Yang&amp;author=P%20Chen&amp;author=Y%20Huang&amp;author=F%20Li&amp;volume=10&amp;publication_year=2018&amp;pages=41118-41128&amp;pmid=30444340&amp;doi=10.1021/acsami.8b14940&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b113-ijo-67-03-05783">
<span class="label">113.</span><cite>Wang Y, Zeng S, Lin TM, Krugner-Higby L, Lyman D, Steffen D, Xiong MP. Evaluating the anticancer properties of liposomal copper in a nude xenograft mouse model of human prostate cancer: Formulation, in vitro, in vivo, histology and tissue distribution studies. Pharm Res. 2014;31:3106–3119. doi: 10.1007/s11095-014-1403-6.</cite> [<a href="https://doi.org/10.1007/s11095-014-1403-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4214917/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24848339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm%20Res&amp;title=Evaluating%20the%20anticancer%20properties%20of%20liposomal%20copper%20in%20a%20nude%20xenograft%20mouse%20model%20of%20human%20prostate%20cancer:%20Formulation,%20in%20vitro,%20in%20vivo,%20histology%20and%20tissue%20distribution%20studies&amp;author=Y%20Wang&amp;author=S%20Zeng&amp;author=TM%20Lin&amp;author=L%20Krugner-Higby&amp;author=D%20Lyman&amp;volume=31&amp;publication_year=2014&amp;pages=3106-3119&amp;pmid=24848339&amp;doi=10.1007/s11095-014-1403-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b114-ijo-67-03-05783">
<span class="label">114.</span><cite>Zhao Y, Wang R, Hu C, Wang Y, Li Z, Yin D, Tan S. Complanatoside A disrupts copper homeostasis and induces cuproptosis via directly targeting ATOX1 in prostate cancer. Toxicol Appl Pharmacol. 2025;496:117257. doi: 10.1016/j.taap.2025.117257.</cite> [<a href="https://doi.org/10.1016/j.taap.2025.117257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39909165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol%20Appl%20Pharmacol&amp;title=Complanatoside%20A%20disrupts%20copper%20homeostasis%20and%20induces%20cuproptosis%20via%20directly%20targeting%20ATOX1%20in%20prostate%20cancer&amp;author=Y%20Zhao&amp;author=R%20Wang&amp;author=C%20Hu&amp;author=Y%20Wang&amp;author=Z%20Li&amp;volume=496&amp;publication_year=2025&amp;pages=117257&amp;pmid=39909165&amp;doi=10.1016/j.taap.2025.117257&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b115-ijo-67-03-05783">
<span class="label">115.</span><cite>Zhou G, Chen C, Wu H, Lin J, Liu H, Tao Y, Huang B. LncRNA AP000842.3 triggers the malignant progression of prostate cancer by regulating cuproptosis related gene NFAT5. Technol Cancer Res Treat. 2024;23:15330338241255585. doi: 10.1177/15330338241255585.</cite> [<a href="https://doi.org/10.1177/15330338241255585" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11119409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38780486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Technol%20Cancer%20Res%20Treat&amp;title=LncRNA%20AP000842.3%20triggers%20the%20malignant%20progression%20of%20prostate%20cancer%20by%20regulating%20cuproptosis%20related%20gene%20NFAT5&amp;author=G%20Zhou&amp;author=C%20Chen&amp;author=H%20Wu&amp;author=J%20Lin&amp;author=H%20Liu&amp;volume=23&amp;publication_year=2024&amp;pages=15330338241255585&amp;pmid=38780486&amp;doi=10.1177/15330338241255585&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b116-ijo-67-03-05783">
<span class="label">116.</span><cite>Farhan M. Cytotoxic activity of the red grape polyphenol resveratrol against human prostate cancer cells: A molecular mechanism mediated by mobilization of nuclear copper and generation of reactive oxygen species. Life (Basel) 2024;14:611. doi: 10.3390/life14050611.</cite> [<a href="https://doi.org/10.3390/life14050611" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11122162/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38792632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20(Basel)&amp;title=Cytotoxic%20activity%20of%20the%20red%20grape%20polyphenol%20resveratrol%20against%20human%20prostate%20cancer%20cells:%20A%20molecular%20mechanism%20mediated%20by%20mobilization%20of%20nuclear%20copper%20and%20generation%20of%20reactive%20oxygen%20species&amp;author=M%20Farhan&amp;volume=14&amp;publication_year=2024&amp;pages=611&amp;pmid=38792632&amp;doi=10.3390/life14050611&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b117-ijo-67-03-05783">
<span class="label">117.</span><cite>Wang X, Chen X, Xu C, Zhou W, Wu D. Identification of cuproptosis-related genes for predicting the development of prostate cancer. Open Med (Wars) 2023;18:20230717. doi: 10.1515/med-2023-0717.</cite> [<a href="https://doi.org/10.1515/med-2023-0717" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10499014/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37711156/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Open%20Med%20(Wars)&amp;title=Identification%20of%20cuproptosis-related%20genes%20for%20predicting%20the%20development%20of%20prostate%20cancer&amp;author=X%20Wang&amp;author=X%20Chen&amp;author=C%20Xu&amp;author=W%20Zhou&amp;author=D%20Wu&amp;volume=18&amp;publication_year=2023&amp;pages=20230717&amp;pmid=37711156&amp;doi=10.1515/med-2023-0717&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b118-ijo-67-03-05783">
<span class="label">118.</span><cite>Cheng B, Tang C, Xie J, Zhou Q, Luo T, Wang Q, Huang H. Cuproptosis illustrates tumor micro-environment features and predicts prostate cancer therapeutic sensitivity and prognosis. Life Sci. 2023;325:121659. doi: 10.1016/j.lfs.2023.121659.</cite> [<a href="https://doi.org/10.1016/j.lfs.2023.121659" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37011878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20Sci&amp;title=Cuproptosis%20illustrates%20tumor%20micro-environment%20features%20and%20predicts%20prostate%20cancer%20therapeutic%20sensitivity%20and%20prognosis&amp;author=B%20Cheng&amp;author=C%20Tang&amp;author=J%20Xie&amp;author=Q%20Zhou&amp;author=T%20Luo&amp;volume=325&amp;publication_year=2023&amp;pages=121659&amp;pmid=37011878&amp;doi=10.1016/j.lfs.2023.121659&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b119-ijo-67-03-05783">
<span class="label">119.</span><cite>Jin L, Mei W, Liu X, Sun X, Xin S, Zhou Z, Zhang J, Zhang B, Chen P, Cai M, Ye L. Identification of cuproptosis-related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer. Front Immunol. 2022;13:974034. doi: 10.3389/fimmu.2022.974034.</cite> [<a href="https://doi.org/10.3389/fimmu.2022.974034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9530990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36203594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Identification%20of%20cuproptosis-related%20subtypes,%20the%20development%20of%20a%20prognosis%20model,%20and%20characterization%20of%20tumor%20microenvironment%20infiltration%20in%20prostate%20cancer&amp;author=L%20Jin&amp;author=W%20Mei&amp;author=X%20Liu&amp;author=X%20Sun&amp;author=S%20Xin&amp;volume=13&amp;publication_year=2022&amp;pages=974034&amp;pmid=36203594&amp;doi=10.3389/fimmu.2022.974034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b120-ijo-67-03-05783">
<span class="label">120.</span><cite>Wang H, Xie M, Zhao Y, Zhang Y. Establishment of a prognostic risk model for prostate cancer based on Gleason grading and cuprotosis related genes. J Cancer Res Clin Oncol. 2024;150:376. doi: 10.1007/s00432-024-05899-9.</cite> [<a href="https://doi.org/10.1007/s00432-024-05899-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11291559/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39085482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cancer%20Res%20Clin%20Oncol&amp;title=Establishment%20of%20a%20prognostic%20risk%20model%20for%20prostate%20cancer%20based%20on%20Gleason%20grading%20and%20cuprotosis%20related%20genes&amp;author=H%20Wang&amp;author=M%20Xie&amp;author=Y%20Zhao&amp;author=Y%20Zhang&amp;volume=150&amp;publication_year=2024&amp;pages=376&amp;pmid=39085482&amp;doi=10.1007/s00432-024-05899-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b121-ijo-67-03-05783">
<span class="label">121.</span><cite>Yao K, Zhang R, Li L, Liu M, Feng S, Yan H, Zhang Z, Xie D. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma. Front Immunol. 2023;14:1181370. doi: 10.3389/fimmu.2023.1181370.</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1181370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10433769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37600770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=The%20signature%20of%20cuproptosis-related%20immune%20genes%20predicts%20the%20tumor%20microenvironment%20and%20prognosis%20of%20prostate%20adenocarcinoma&amp;author=K%20Yao&amp;author=R%20Zhang&amp;author=L%20Li&amp;author=M%20Liu&amp;author=S%20Feng&amp;volume=14&amp;publication_year=2023&amp;pages=1181370&amp;pmid=37600770&amp;doi=10.3389/fimmu.2023.1181370&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b122-ijo-67-03-05783">
<span class="label">122.</span><cite>Zhang J, Jiang S, Gu D, Zhang W, Shen X, Qu M, Yang C, Wang Y, Gao X. Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer. Front Oncol. 2023;13:1162653. doi: 10.3389/fonc.2023.1162653.</cite> [<a href="https://doi.org/10.3389/fonc.2023.1162653" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10185853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37205181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Identification%20of%20novel%20molecular%20subtypes%20and%20a%20signature%20to%20predict%20prognosis%20and%20therapeutic%20response%20based%20on%20cuproptosis-related%20genes%20in%20prostate%20cancer&amp;author=J%20Zhang&amp;author=S%20Jiang&amp;author=D%20Gu&amp;author=W%20Zhang&amp;author=X%20Shen&amp;volume=13&amp;publication_year=2023&amp;pages=1162653&amp;pmid=37205181&amp;doi=10.3389/fonc.2023.1162653&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b123-ijo-67-03-05783">
<span class="label">123.</span><cite>Ma S, Xu M, Zhang J, Li T, Zhou Q, Xi Z, Wang Z, Wang J, Ge Y. Analysis and functional validations of multiple cell death patterns for prognosis in prostate cancer. Int Immunopharmacol. 2024;143(Pt 1):113216. doi: 10.1016/j.intimp.2024.113216.</cite> [<a href="https://doi.org/10.1016/j.intimp.2024.113216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39353397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Immunopharmacol&amp;title=Analysis%20and%20functional%20validations%20of%20multiple%20cell%20death%20patterns%20for%20prognosis%20in%20prostate%20cancer&amp;author=S%20Ma&amp;author=M%20Xu&amp;author=J%20Zhang&amp;author=T%20Li&amp;author=Q%20Zhou&amp;volume=143&amp;issue=Pt%201&amp;publication_year=2024&amp;pages=113216&amp;pmid=39353397&amp;doi=10.1016/j.intimp.2024.113216&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b124-ijo-67-03-05783">
<span class="label">124.</span><cite>Cheng X, Zeng Z, Yang H, Chen Y, Liu Y, Zhou X, Zhang C, Wang G. Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma. BMC Cancer. 2023;23:105. doi: 10.1186/s12885-023-10584-0.</cite> [<a href="https://doi.org/10.1186/s12885-023-10584-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9887873/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36717792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Novel%20cuproptosis-related%20long%20non-coding%20RNA%20signature%20to%20predict%20prognosis%20in%20prostate%20carcinoma&amp;author=X%20Cheng&amp;author=Z%20Zeng&amp;author=H%20Yang&amp;author=Y%20Chen&amp;author=Y%20Liu&amp;volume=23&amp;publication_year=2023&amp;pages=105&amp;pmid=36717792&amp;doi=10.1186/s12885-023-10584-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b125-ijo-67-03-05783">
<span class="label">125.</span><cite>Ma Z, Liang H, Cui R, Ji J, Liu H, Liu X, Shen P, Wang H, Wang X, Song Z, Jiang Y. Construction of a risk model and prediction of prognosis and immunotherapy based on cuproptosis-related LncRNAs in the urinary system pan-cancer. Eur J Med Res. 2023;28:198. doi: 10.1186/s40001-023-01173-9.</cite> [<a href="https://doi.org/10.1186/s40001-023-01173-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10294367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37370148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Med%20Res&amp;title=Construction%20of%20a%20risk%20model%20and%20prediction%20of%20prognosis%20and%20immunotherapy%20based%20on%20cuproptosis-related%20LncRNAs%20in%20the%20urinary%20system%20pan-cancer&amp;author=Z%20Ma&amp;author=H%20Liang&amp;author=R%20Cui&amp;author=J%20Ji&amp;author=H%20Liu&amp;volume=28&amp;publication_year=2023&amp;pages=198&amp;pmid=37370148&amp;doi=10.1186/s40001-023-01173-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b126-ijo-67-03-05783">
<span class="label">126.</span><cite>Jiang S, Li Z, Dou R, Lin Z, Zhang J, Zhang W, Chen Z, Shen X, Ji J, Qu M, et al.  Construction and validation of a novel cuproptosis-related long noncoding RNA signature for predicting the outcome of prostate cancer. Front Genet. 2022;13:976850. doi: 10.3389/fgene.2022.976850.</cite> [<a href="https://doi.org/10.3389/fgene.2022.976850" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9763621/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36561322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Genet&amp;title=Construction%20and%20validation%20of%20a%20novel%20cuproptosis-related%20long%20noncoding%20RNA%20signature%20for%20predicting%20the%20outcome%20of%20prostate%20cancer&amp;author=S%20Jiang&amp;author=Z%20Li&amp;author=R%20Dou&amp;author=Z%20Lin&amp;author=J%20Zhang&amp;volume=13&amp;publication_year=2022&amp;pages=976850&amp;pmid=36561322&amp;doi=10.3389/fgene.2022.976850&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b127-ijo-67-03-05783">
<span class="label">127.</span><cite>Zhong H, Lai Y, Ouyang W, Yu Y, Wu Y, He X, Zeng L, Qiu X, Chen P, Li L, et al.  Integrative analysis of cuproptosis-related lncRNAs: Unveiling prognostic significance, immune microenvironment, and copper-induced mechanisms in prostate cancer. Cancer Pathog Ther. 2024;3:48–59. doi: 10.1016/j.cpt.2024.03.004.</cite> [<a href="https://doi.org/10.1016/j.cpt.2024.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11764251/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39872368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Pathog%20Ther&amp;title=Integrative%20analysis%20of%20cuproptosis-related%20lncRNAs:%20Unveiling%20prognostic%20significance,%20immune%20microenvironment,%20and%20copper-induced%20mechanisms%20in%20prostate%20cancer&amp;author=H%20Zhong&amp;author=Y%20Lai&amp;author=W%20Ouyang&amp;author=Y%20Yu&amp;author=Y%20Wu&amp;volume=3&amp;publication_year=2024&amp;pages=48-59&amp;pmid=39872368&amp;doi=10.1016/j.cpt.2024.03.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b128-ijo-67-03-05783">
<span class="label">128.</span><cite>Ren L, Yang X, Wang W, Lin H, Huang G, Liu Z, Pan J, Mao X. A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer. Front Genet. 2023;14:1096783. doi: 10.3389/fgene.2023.1096783.</cite> [<a href="https://doi.org/10.3389/fgene.2023.1096783" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9999016/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36911392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Genet&amp;title=A%20cuproptosis-related%20LncRNA%20signature:%20Integrated%20analysis%20associated%20with%20biochemical%20recurrence%20and%20immune%20landscape%20in%20prostate%20cancer&amp;author=L%20Ren&amp;author=X%20Yang&amp;author=W%20Wang&amp;author=H%20Lin&amp;author=G%20Huang&amp;volume=14&amp;publication_year=2023&amp;pages=1096783&amp;pmid=36911392&amp;doi=10.3389/fgene.2023.1096783&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b129-ijo-67-03-05783">
<span class="label">129.</span><cite>Yu Z, Deng H, Chao H, Song Z, Zeng T. Construction of a cuproptosis-related lncRNA signature to predict biochemical recurrence of prostate cancer. Oncol Lett. 2024;28:526. doi: 10.3892/ol.2024.14659.</cite> [<a href="https://doi.org/10.3892/ol.2024.14659" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11391508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39268161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Lett&amp;title=Construction%20of%20a%20cuproptosis-related%20lncRNA%20signature%20to%20predict%20biochemical%20recurrence%20of%20prostate%20cancer&amp;author=Z%20Yu&amp;author=H%20Deng&amp;author=H%20Chao&amp;author=Z%20Song&amp;author=T%20Zeng&amp;volume=28&amp;publication_year=2024&amp;pages=526&amp;pmid=39268161&amp;doi=10.3892/ol.2024.14659&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b130-ijo-67-03-05783">
<span class="label">130.</span><cite>Lu Y, Wu J, Li X, Leng Q, Tan J, Huang H, Zhong R, Chen Z, Zhang Y. Cuproptosis-related lncRNAs emerge as a novel signature for predicting prognosis in prostate carcinoma and functional experimental validation. Front Immunol. 2024;15:1471198. doi: 10.3389/fimmu.2024.1471198.</cite> [<a href="https://doi.org/10.3389/fimmu.2024.1471198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11550951/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39530098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Cuproptosis-related%20lncRNAs%20emerge%20as%20a%20novel%20signature%20for%20predicting%20prognosis%20in%20prostate%20carcinoma%20and%20functional%20experimental%20validation&amp;author=Y%20Lu&amp;author=J%20Wu&amp;author=X%20Li&amp;author=Q%20Leng&amp;author=J%20Tan&amp;volume=15&amp;publication_year=2024&amp;pages=1471198&amp;pmid=39530098&amp;doi=10.3389/fimmu.2024.1471198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b131-ijo-67-03-05783">
<span class="label">131.</span><cite>Nyvltova E, Dietz JV, Seravalli J, Khalimonchuk O, Barrientos A. Coordination of metal center biogenesis in human cytochrome c oxidase. Nat Commun. 2022;13:3615. doi: 10.1038/s41467-022-31413-1.</cite> [<a href="https://doi.org/10.1038/s41467-022-31413-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9232578/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35750769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Coordination%20of%20metal%20center%20biogenesis%20in%20human%20cytochrome%20c%20oxidase&amp;author=E%20Nyvltova&amp;author=JV%20Dietz&amp;author=J%20Seravalli&amp;author=O%20Khalimonchuk&amp;author=A%20Barrientos&amp;volume=13&amp;publication_year=2022&amp;pages=3615&amp;pmid=35750769&amp;doi=10.1038/s41467-022-31413-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b132-ijo-67-03-05783">
<span class="label">132.</span><cite>Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X. Copper metabolism in cell death and autophagy. Autophagy. 2023;19:2175–2195. doi: 10.1080/15548627.2023.2200554.</cite> [<a href="https://doi.org/10.1080/15548627.2023.2200554" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10351475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37055935/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Autophagy&amp;title=Copper%20metabolism%20in%20cell%20death%20and%20autophagy&amp;author=Q%20Xue&amp;author=R%20Kang&amp;author=DJ%20Klionsky&amp;author=D%20Tang&amp;author=J%20Liu&amp;volume=19&amp;publication_year=2023&amp;pages=2175-2195&amp;pmid=37055935&amp;doi=10.1080/15548627.2023.2200554&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b133-ijo-67-03-05783">
<span class="label">133.</span><cite>Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J, et al.  Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493–500. doi: 10.1038/s41586-024-07487-w.</cite> [<a href="https://doi.org/10.1038/s41586-024-07487-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11168924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38718835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Accurate%20structure%20prediction%20of%20biomolecular%20interactions%20with%20AlphaFold%203&amp;author=J%20Abramson&amp;author=J%20Adler&amp;author=J%20Dunger&amp;author=R%20Evans&amp;author=T%20Green&amp;volume=630&amp;publication_year=2024&amp;pages=493-500&amp;pmid=38718835&amp;doi=10.1038/s41586-024-07487-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Not applicable.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from International Journal of Oncology are provided here courtesy of <strong>Spandidos Publications</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3892/ijo.2025.5783"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ijo-67-03-05783.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12331299/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12331299/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12331299%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331299/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12331299/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12331299/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40776742/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12331299/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40776742/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12331299/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12331299/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="ypQyXuoQG5qVxMZGCRb6DlbzH8i8jjweeKZqvU6gU3pHNJnqvSwxELNTYSd1BZCX">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
